Venus Concept (VERO) 10-K 28 Mar 22 2021 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2021	Mar. 24, 2022	Jun. 30, 2021
Document Information [Line Items]
Entity Central Index Key	0001409269
Entity Registrant Name	Venus Concept Inc.
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2021
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2021
Document Transition Report	false
Entity File Number	001-38238
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	06-1681204
Entity Address, Address Line One	235 Yorkland Blvd. Suite 900
Entity Address, City or Town	Toronto
Entity Address, State or Province	ON
Entity Address, Postal Zip Code	M2J 4Y8
City Area Code	877
Local Phone Number	848-8430
Title of 12(b) Security	Common Stock, $0.0001 par value per share
Trading Symbol	VERO
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	false
Entity Public Float			$ 107,494,503
Entity Common Stock, Shares Outstanding		63,999,044
Auditor Name	MNP LLP
Auditor Location	Toronto, Canada
Auditor Firm ID	1930

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
CURRENT ASSETS:
Cash and cash equivalents	$ 30,876	$ 34,297
Restricted cash	0	83
Accounts receivable, net of allowance of $11,997 and $18,490 as of December 31, 2021, and 2020	46,918	52,764
Inventories	20,543	17,759
Prepaid expenses	2,737	2,240
Advances to suppliers	2,162	2,587
Other current assets	3,758	5,674
Total current assets	106,994	115,404
LONG-TERM ASSETS:
Long-term trade receivables	27,710	21,148
Deferred tax assets	284	884
Severance pay funds	817	685
Property and equipment, net	2,669	3,539
Intangible assets	15,393	18,865
Total long-term assets	46,873	45,121
TOTAL ASSETS	153,867	160,525
CURRENT LIABILITIES:
Trade payables	4,913	6,322
Accrued expenses and other current liabilities	19,512	20,253
Income taxes payable	294	1,132
Unearned interest income	2,678	1,950
Warranty accrual	1,245	1,106
Deferred revenues	2,030	1,752
Current portion of government assistance loans	543	0
Total current liabilities	31,215	32,515
LONG-TERM LIABILITIES:
Long-term debt	77,325	75,491
Government assistance loans	0	4,110
Income tax payable	563	478
Accrued severance pay	911	755
Deferred tax liabilities	46	811
Unearned interest income	1,355	1,778
Warranty accrual	508	533
Other long-term liabilities	348	293
Total long-term liabilities	81,056	84,249
TOTAL LIABILITIES	112,271	116,764
Commitments and Contingencies (Note 9)
STOCKHOLDERS’ EQUITY (Note 1):
Common Stock, $0.0001 par value: 300,000,000 shares authorized as of December 31, 2021 and 2020; 63,982,580 and 53,551,126 issued and outstanding as of December 31, 2021 and 2020, respectively	27	26
Additional paid-in capital	221,321	201,598
Accumulated deficit	(180,405)	(157,392)
TOTAL STOCKHOLDERS’ EQUITY	40,943	44,232
Non-controlling interests	653	(471)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance	41,596	43,761
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 153,867	$ 160,525

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Accounts receivable, allowance, current	$ 11,997	$ 18,490
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	300,000,000	300,000,000
Common stock, shares issued (in shares)	63,982,580	53,551,126
Common stock, shares outstanding (in shares)	63,982,580	53,551,126

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Revenue
Revenues	$ 105,622	$ 78,014
Cost of goods sold
Cost of goods and services sold	31,528	26,623
Gross profit	74,094	51,391
Operating expenses:
Selling and marketing	37,438	26,203
General and administrative	45,940	57,882
Research and development	8,258	7,754
Goodwill impairment	0	27,450
Total operating expenses	88,861	119,289
Loss from operations	(14,767)	(67,898)
Other expenses:
Foreign exchange loss (gain)	2,559	(68)
Finance expenses	4,955	8,343
Loss on disposal of subsidiaries	567	2,526
Loss before income taxes	(22,848)	(81,637)
Income tax (benefit) expense	(707)	1,181
Net loss	(22,141)	(82,818)
Deemed dividend (Note 15)	0	3,564
Net loss attributable to stockholders of the Company	(23,013)	(85,270)
Net income (loss) attributable to non-controlling interest	$ 872	$ (1,112)
Net loss per share:
Basic (in dollars per share)	$ (0.42)	$ (2.33)
Diluted (in dollars per share)	$ (0.42)	$ (2.33)
Weighted-average number of shares used in per share calculation:
Basic (in shares)	54,466	36,626
Diluted (in shares)	54,466	36,626
Government Assistance Loans [Member]
Operating expenses:
Gain (loss) on debt extinguishment	$ (2,775)	$ 0
Other expenses:
Gain (loss) on debt extinguishment	(2,775)	0
Secured Subordinated Convertible Notes [Member] | Madryn Noteholders [Member]
Operating expenses:
Gain (loss) on debt extinguishment	0	2,938
Other expenses:
Gain (loss) on debt extinguishment	0	2,938
Leases [Member]
Revenue
Revenues	45,094	33,428
Cost of goods sold
Cost of goods and services sold	10,459	7,899
Products and Services [Member]
Revenue
Revenues	60,528	44,586
Cost of goods sold
Cost of goods and services sold	$ 21,069	$ 18,724

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Net loss	$ (22,141)	$ (82,818)
Deemed dividend (Note 15)	0	3,564
Net loss attributable to stockholders of the Company	(23,013)	(85,270)
Income (loss) attributable to non-controlling interest	872	(1,112)
Comprehensive loss	$ (22,141)	$ (82,818)

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Equity - USD ($) $ in Thousands	Private Placement [Member]Preferred Stock [Member]Series A Preferred Stock [Member]	Private Placement [Member]Common Stock [Member]	Private Placement [Member]Additional Paid-in Capital [Member]	Private Placement [Member]AOCI Attributable to Parent [Member]	Private Placement [Member]Noncontrolling Interest [Member]	Private Placement [Member]	December 2020 Public Offering [Member]Preferred Stock [Member]Series A Preferred Stock [Member]	December 2020 Public Offering [Member]Common Stock [Member]	December 2020 Public Offering [Member]Additional Paid-in Capital [Member]	December 2020 Public Offering [Member]AOCI Attributable to Parent [Member]	December 2020 Public Offering [Member]Noncontrolling Interest [Member]	December 2020 Public Offering [Member]	Series A Preferred Stock Converted into Common Stock [Member]Preferred Stock [Member]Series A Preferred Stock [Member]	Series A Preferred Stock Converted into Common Stock [Member]Common Stock [Member]	Series A Preferred Stock Converted into Common Stock [Member]Additional Paid-in Capital [Member]	Series A Preferred Stock Converted into Common Stock [Member]AOCI Attributable to Parent [Member]	Series A Preferred Stock Converted into Common Stock [Member]Noncontrolling Interest [Member]	Series A Preferred Stock Converted into Common Stock [Member]	Preferred Stock [Member]Series A Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Noncontrolling Interest [Member]	Series A Preferred Stock [Member]	Total
Balance (in shares) at Dec. 31, 2019																			0	28,686,116
Balance at Dec. 31, 2019																			$ 0	$ 24	$ 149,840	$ (75,686)	$ 2,500		$ 76,678
Issuance of common stock (in shares)																			0	4,245,256
Issuance of common stock																			$ 0		8,490				8,490
Shares and warrants, net of costs (in shares)	660,000	2,300,000					0	11,250,000
Shares and warrants, net of costs	$ 0	$ 0	$ 16,736	$ 0	$ 0	$ 16,736	$ 0	$ 1	$ 20,475	$ 0	$ 0	$ 20,476
Conversion into common stock (in shares)													(660,000)	6,600,000
Conversion into common stock													$ 0	$ 1	$ (1)	$ 0	$ 0	$ 0
Deemed dividends																			0	0	3,564	0	0		3,564
Dividends from subsidiaries																			0	0	0	0	(218)		(218)
Net loss — the Company																			0	0	0	(81,706)	0		(81,706)
Net loss — non-controlling interest																			$ 0	$ 0	0	0	(1,112)		(1,112)
Options exercised (in shares)																			0	469,754
Options exercised																			$ 0	$ 0	356	0	0		356
Disposal of subsidiary																			0	0	0	0	(1,641)		(1,641)
Stock-based compensation																			0	0	2,138	0	0		2,138
Disposal of subsidiary																			$ 0	$ 0	0	0	1,641		1,641
Balance (in shares) at Dec. 31, 2020																			0	53,551,126
Balance at Dec. 31, 2020																			$ 0	$ 26	201,598	(157,392)	(471)		43,761
Issuance of common stock (in shares)	3,790,755	9,808,418
Issuance of common stock	$ 0	$ 1	$ 16,587	$ 0	$ 0	$ 16,588
Dividends from subsidiaries																			0	0	0	0	(293)		(293)
Net loss — the Company																			0	0	0	(23,013)	0		(23,013)
Net loss — non-controlling interest																			$ 0	$ 0	0	0	872		$ 872
Options exercised (in shares)																			0	261,836					261,836
Options exercised																			$ 0	$ 0	354	0	0		$ 354
Disposal of subsidiary																			0	0	0	0	(204)		(204)
Stock-based compensation																			$ 0	$ 0	2,068	0	0		2,068
December 2020 Public Offering warrants exercise (in shares)																			0	361,200
December 2020 Public Offering warrants exercise																			$ 0	$ 0	903	0	0		903
Beneficial conversion feature																			0	0	152	0	0	$ 152	152
Acquisition of non-controlling interest																			0	0	(341)	0	341		0
Disposal of subsidiary																			$ 0	$ 0	0	0	204		204
Balance (in shares) at Dec. 31, 2021																			3,790,755	63,982,580
Balance at Dec. 31, 2021																			$ 0	$ 27	$ 221,321	$ (180,405)	$ 653		$ 41,596

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (22,141)	$ (82,818)
Adjustments to reconcile net loss to net cash used in operating activities:
Goodwill impairment	0	27,450
Depreciation and amortization	4,854	4,804
Stock-based compensation	2,068	2,138
Bad debt (recovery) provision for bad debt	(263)	15,212
Provision for inventory obsolescence	1,456	610
Finance expenses and accretion	1,779	6,091
Deferred tax benefit	(165)	(438)
Interest on convertible promissory notes	0	135
Change in fair value of earn-out liability	0	291
Loss on sale of subsidiaries	567	2,526
Loss on disposal of property and equipment	0	162
Unrealized foreign exchange loss	0	(30)
Changes in operating assets and liabilities:
Accounts receivable short- and long-term	(869)	93
Inventories	(4,261)	(1,020)
Prepaid expenses	(454)	233
Advances to suppliers	425	0
Other current assets	1,908	(2,359)
Other long-term assets	(98)	(162)
Trade payables	(1,409)	(2,979)
Accrued expenses and other current liabilities	(889)	857
Severance payments	(132)	25
Unearned interest income	305	(1,895)
Other long-term liabilities	323	(514)
Net cash used in operating activities	(19,771)	(28,650)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(512)	(291)
Cash received from sale of subsidiaries, net of cash relinquished	(40)	(2,101)
Net cash used in investing activities	(552)	(2,392)
CASH FLOWS FROM FINANCING ACTIVITIES:
Exercises of 2020 December Public Offering Warrants	903	0
(Repayment) issuance of long-term debt	0	(43,649)
Repayment of line-of-credit	0	(7,813)
(Repayment of) proceeds from government assistance loans	(738)	4,110
Proceeds from issuance of common stock, net of costs	0	8,390
Dividends from subsidiaries paid to non-controlling interest	(293)	(218)
Payment of earn-out liability	(147)	(799)
Annual installment payments	0	(250)
Proceeds from exercise of options	354	356
Net cash provided by financing activities	16,819	49,673
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH	(3,504)	18,631
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH — Beginning of year	34,380	15,749
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH — End of year	30,876	34,380
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for income taxes	116	941
Cash paid for interest	3,292	1,470
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING INFORMATION:
Beneficial conversion factor of preferred stock accreted as deemed dividend	0	3,564
Assets received from sale of subsidiaries	0	2,918
Conversion of Madryn Loan into Convertible Notes [Member]
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING INFORMATION:
Conversion of debt	0	26,695
Series A Preferred Stock Converted into Common Stock [Member]
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING INFORMATION:
Conversion of Series A convertible preferred stock	0	660
The 2021 Private Placement [Member]
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from Private Placement, net of costs	16,740	0
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING INFORMATION:
2021 Private Placement costs	259	0
The 2020 Private Placement [Member]
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from Private Placement, net of costs	0	20,300
December 2020 Public Offering [Member]
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock, net of costs	0	20,475
MSLP Loan Agreement [Member]
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of MSLP loan, net of cash financing fees of $1,229	0	48,771
Secured Subordinated Convertible Notes [Member]
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING INFORMATION:
Issuance of convertible promissory notes	0	26,695
Secured Subordinated Convertible Notes [Member] | Madryn Noteholders [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Gain (loss) on debt extinguishment	0	2,938
Government Assistance Loans [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Gain (loss) on debt extinguishment	$ (2,775)	$ 0

Consolidated Statements of Ca_2

Consolidated Statements of Cash Flows (Parentheticals) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
MSLP Loan Agreement [Member]
Financing fees		$ 1,229
The 2021 Private Placement [Member]
Stock issuance costs	$ 259
The 2020 Private Placement [Member]
Stock issuance costs		1,951
December 2020 Public Offering [Member]
Stock issuance costs		$ 2,025

Note 1 - Nature of Operations

Note 1 - Nature of Operations	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Nature of Operations [Text Block]	1. Venus Concept Inc. is a global medical technology company that develops, commercializes, and sells minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The Company’s systems have been designed on cost-effective, proprietary and flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family and general practitioners and aesthetic medical spas. The Company was incorporated in the state of Delaware on November 22, 2002. Going Concern The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the foreseeable future, and, as such, the consolidated financial statements do not The Company has had recurring net operating losses and negative cash flows from operations. As of December 31, 2021 December 31, 2020 December 31, 2021 December 31, 2020 12 19” December 31, 2021 In order to continue its operations, the Company must achieve profitable operations and/or obtain additional equity or debt financing. Until the Company achieves profitability, management plans to fund its operations and capital expenditures with cash on hand, borrowings, and issuance of capital stock. In December 2021, 2021 December 22, 2020, “December 2020 “December 2020 December 2020 five February 2021, December 2020 December 2020 Given the pandemic and the uncertainty around the COVID- 19 may no may not The 2021 In December 2021, “2021 2021 December 15, 2021. 2021 2021 2021 2021 15. Equity Purchase Agreement with Lincoln Park On June 16, 2020, may may no no 5635 no may In 2020 December 31, 2020. December 31, 2021 were $9,010, which were then reduced by the amortization of deferred issuance costs of $520. Gross proceeds in the amount of $9,010 2021. Sale of subsidiaries In 2020, not not not not 205 20 45. 2021, $567 rec 4

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Significant Accounting Policies [Text Block]	2. Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (U.S. GAAP). Principles of Consolidation The accompanying consolidated financial statements include the accounts of Venus Concept Inc. and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated on consolidation. Where the Company does not 100% Use of Estimates The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates and assumptions made in the accompanying consolidated financial statements include, but are not The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID- 19 December 31, 2021 not 19 $nil December 31, 2021 December 31, 2020 $27,450 (Note 8 March 31, 2020. Foreign Currency The consolidated financial statements are presented in U.S. dollars. Amounts reported in thousands within this report are computed based on the amounts in dollars. As a result, the sum of the components reported in thousands may not may not All exchange gains and losses from remeasurement of monetary balance sheet items resulting from transactions in non-functional currencies are recorded in the consolidated statements of operations as they arise. In respect of transactions denominated in currencies other than the Company and its subsidiaries’ functional currencies, the monetary assets and liabilities are remeasured at the period end rates. Revenue and expenses are remeasured at rates of exchange prevailing on the transaction dates. All of the exchange gains or losses resulting from these transactions are recognized in the consolidated statements of operations. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three Restricted Cash As of December 31, 2021 2020 $nil Concentration of Credit Risk Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents, accounts receivable and long-term receivables. The Company’s cash and cash equivalents are invested primarily in deposits with major banks worldwide, as such minimal credit risk exists with respect to such investments. The Company’s trade receivables are derived from global sales to customers. An allowance for doubtful accounts is provided with respect to all balances for which collection is deemed to be doubtful. Risks and Uncertainties The Company has considered the impact of COVID- 19 19 2020, December 31, 2021 may not Besides COVID- 19, not may may The Company has borrowings with interest rates that are subject to fluctuations as charged by the lender. The Company does not December 31, 2021 2020 Concentration of Customers For the years ended December 31, 2021 2020 10% 10% Allowance for Doubtful Accounts Trade accounts receivable do not not may December 31, 2021 2020 Inventory Inventories are stated at the lower of cost or net realizable value and include raw materials, work in progress and finished goods. Cost is determined as follows: Raw Materials and Work in Progress (“WIP”) – Cost is determined on a standard cost basis utilizing the weighted average cost of historical purchases, which approximates actual cost. The cost of WIP and finished goods includes the cost of raw materials and the applicable share of the cost of labor and fixed and variable production overheads. The Company regularly evaluates the value of inventory based on a combination of factors including the following: historical usage rates, product end of life dates, technological obsolescence and product introductions. The Company includes demonstration units within inventories. Proceeds from the sale of demonstration units are recorded as revenue. Long-term Receivables Long-term receivables relate to the Company’s subscription revenue or contracts which stipulate payment terms which exceed one 2021 2020 Deferred revenues represent payments received prior to the income being earned. Once the equipment has been delivered or the services have been rendered, these amounts are recognized in income. Property and Equipment Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, which is between three ten Intangible Assets Intangible assets consist of customer relationships, brand, technology and supplier agreement. Intangible assets are stated at cost less accumulated amortization. Amortization is computed using the straight-line method over the estimated useful lives of the respective assets, which range from approximately six fifteen The useful lives of intangible assets are based on the Company’s assessment of various factors impacting estimated cash flows, such as the product’s position in its lifecycle, the existence or absence of like products in the market, various other competitive and regulatory issues, and contractual terms. Impairment of Long-Lived Assets The Company accounts for the impairment of long-lived assets in accordance with FASB, Accounting Standards Codification (“ASC”) 360 10, may not December 31, 2021 2020 Goodwill Goodwill represents the excess of the purchase price of the business acquired over the fair value of the net identifiable assets of an acquired business. The Company allocates goodwill to reporting units at the time of acquisition or when there is a change in the reporting structure and bases that allocation on which reporting units will benefit from the acquired assets and liabilities. Reporting units are defined as operating segments or one Goodwill is not may not may 19 first three 2020, 19 March 31, 2020. The Company has one reporting unit and the reporting unit’s carrying value was compared to its estimated fair value. As of March 31, 2020, March 31, 2020, December 31, 2021 2020 no Debt Issuance Costs Costs related to the issuance of debt are presented as a direct deduction to the carrying value of the debt and are amortized to accretion expenses using the effective interest rate method over the term of the related debt. Derivatives The Company reviews the terms of convertible notes, equity instruments and other financing arrangements to determine whether there are embedded derivative instruments, including embedded conversion options that are required to be bifurcated and accounted for separately as a derivative financial instrument. Derivative financial instruments are initially measured at their fair value. Derivative financial instruments that are accounted for as liabilities, are initially recorded at fair value and then re-valued at each reporting date, with changes in the fair value recognized in the consolidated statements of operations. Revenue Recognition The Company adopted Accounting Standards Codification (“ASC”) 606 606” January 1, 2019 not 606 The Company generates revenue from ( 1 2 3 2two5 fourth 2021. 2two5 third 2020. 2two5 not 2020 Many of the Company’s products are sold under subscription contracts with control passing to the customer at the earlier of the end of the term and when the payment is received in full. The subscription contracts include an initial deposit followed by monthly installments typically over a period of 36 months. In accordance with ASC 840 840” The Company recognizes revenues on other products and services in accordance with ASC 606. five 1 2 3 4 5 The Company does not Cost of Goods For subscription sales (qualifying as sales-type lease arrangements) and product sales, the costs are recognized upon shipment to the customer or distributor. Advertising Costs The cost of advertising and media is expensed as incurred. For the years ended December 31, 2021 2020 Research and Development Research and development costs are charged to operations as incurred. Major components of research and development expenses consist of personnel costs, including salaries and benefits, hardware and software research and development costs, regulatory affairs, and clinical costs. Warranty The Company provides a standard warranty against defects for all of its systems. The warranty period begins upon shipment and is typically for a period between one three The Company records a liability for accrued warranty costs at the time of sale of a system, which consists of the warranty on products sold based on historical warranty costs and management’s estimates. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts thereof as necessary. The Company also provides an extended warranty service. Extended warranty can be purchased at any time after the purchase of a system and prior to the expiration of the standard warranty provided with the sale of the system. Extended warranty services include standard warranty services. The Company recognizes the revenue from the sale of an extended warranty over the period of the extended warranty and accounts it for separately from the standard warranty. Income Taxes The Company follows the deferred income taxes method of accounting for income taxes. Under this method, deferred income taxes are recognized for the future tax consequences attributable to differences between the financial statement carrying values of accounts and their respective income tax basis. Deferred income tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years during which the temporary differences are expected to be realized or settled. The effect on deferred income tax assets and liabilities of a change in tax rates is included in income in the period that includes the enactment date. The Company establishes valuation allowances when necessary to reduce deferred tax assets to the amounts that are more likely than not not” not not” not Uncertain Tax Positions The Company recognizes the effect of income tax positions only if those positions are more likely than not first not second 50% The Company considers many factors when evaluating and estimating its tax positions and tax benefits, which may Stock-Based Compensation The Company accounts for stock-based compensation in accordance with ASC 718, 718” 718 The fair value of stock options (“options”) on the grant date is estimated using the Black-Scholes option-pricing model using the single-option approach. The Black-Scholes option pricing model requires the use of highly subjective and complex assumptions, including the option’s expected term and the price volatility of the underlying stock, to determine the fair value of the award. The Company recognizes compensation expenses for the value of its awards granted based on the straight-line method over the requisite service period of each of the awards. The Company has made a policy choice to account for forfeitures when they occur. Net Loss Per Share The Company computes net (loss) income per share in accordance with ASC Topic 260, 260” two two not Diluted net (loss) income per share is the same as basic net (loss) income per share for the periods in which the Company had a net loss because the inclusion of outstanding common stock equivalents would be anti-dilutive. JOBS Act Accounting Election The Company is an emerging growth company, as defined in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it is (i) no may not Recently Issued Accounting Standards Not In April 2020, 842 840: 19 19. 19 not In March 2020, 2020 04 848 2021, March 12, 2020 December 31, 2022. may no December 31, 2022. January 2021, may 848. In February 2020, 2020 02 326 842 326 842. 326, 326 January 1, 2023, In December 2019, 2019 12 740 first 2022,

Note 3 - Net Loss Per Share

Note 3 - Net Loss Per Share	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Earnings Per Share [Text Block]	3. Basic net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding during the period, without consideration for common stock equivalents. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common stock equivalents outstanding for the period determined using the treasury-stock method. For purposes of this calculation, common stock warrants and stock options are considered to be common stock equivalents and are only included in the calculation of diluted net loss per share when their effect is dilutive. The following table sets forth the computation of basic and diluted net loss and the weighted average number of shares used in computing basic and diluted net loss per share (in thousands, except per share data): For the year ended December 31, 2021 2020 Numerator: Net loss $ (22,141 ) $ (82,818 ) Net loss allocated to stockholders of the Company $ (23,013 ) $ (85,270 ) Denominator: Weighted-average shares of common stock outstanding used in computing net loss per share, basic and diluted 54,466 36,626 Net loss per share: Basic and diluted $ (0.42 ) $ (2.33 ) Due to the net loss, all the outstanding shares of common stock equivalents were excluded from the calculation of diluted net loss per share attributable to common stockholders for the years ended December 31, 2021 2020 December 31, 2021 2020 Options to purchase common stock 5,977,179 4,433,392 Warrants for common stock 15,928,867 16,290,067 Total potential dilutive shares 21,906,046 20,723,459

Note 4 - Sale of Subsidiaries

Note 4 - Sale of Subsidiaries	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Mergers, Acquisitions and Dispositions Disclosures [Text Block]	4 . SALE OF SUBSIDIARIES Beginning in 2020, not December 31, 2021 • S old its share (80%) in its subsidiary, Venus Concept Africa (Pty) Ltd., to a non-controlling shareholder for a nominal cash consideration. The disposal resulted in a loss of approximately $188. • Filed a Certificate of Dissolution to dissolve its wholly-owned subsidiary, Restoration Robotics Spain S.L. There is no As these disposals did not not not 205 20 45. In addition to the above, on September 7, 2021, In 2020, third 2021 2020, December 31, 2020, • Sold its share (51%) in its Bulgarian subsidiary, Venus Concept Central Eastern Europe Ltd., to an unrelated third • Sold its share (51%) in its Indian subsidiary, Venus Aesthetic LLP, to an unrelated third • Sold its share (51%) in its Italian subsidiary, Venus Concept Italy S.r.l., to an unrelated third • Entered into a Termination Agreement of the Venus Concept Kazakhstan LLP Foundation Agreement, resulting in the cancellation of its 51% interest in the entity. This disposal resulted in a gain of approximately $58. • Sold its share (51%) of its Russian subsidiary, Venus Concept RU LLC, to an unrelated third • Sold its share (55%) of its Singaporean subsidiary, Venus Concept Singapore Pte. Ltd., including its wholly owned subsidiary, Venus Concept Vietnam Co., Ltd., to a third • Sold its share (100%) in its Indonesian subsidiary, InPhronics Limited, along with its 90% interest in its subsidiary, PT NeoAsia Medical, for the cash consideration of $955. The disposal resulted in a loss of approximately $33.

Note 5 - Fair Value Measurement

Note 5 - Fair Value Measurements	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Fair Value Disclosures [Text Block]	5. Financial assets and financial liabilities are initially recognized at fair value when the Company becomes a party to the contractual provisions of the financial instrument. Subsequently, all financial instruments are measured at amortized cost using the effective interest method. The financial instruments of the Company consist of cash and cash equivalents, restricted cash, accounts receivable, long-term receivables, lines of credit, trade payables, government assistance loans, accrued expenses and other current liabilities, earn-out liability, other long-term liabilities and long-term debt. In view of their nature, the fair value of these financial instruments approximates their carrying amounts. The Company measures the fair value of its financial assets and financial liabilities using the fair value hierarchy. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The accounting guidance establishes a three Level 1 Level 2 1 not Level 3 no The Company classifies its restricted cash within Level 1. 2 3. 1, 2 3 Fair Value Measurements as of December 31, 2021 Quoted Prices in Active Markets using Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Assets Guaranteed Investment Certificates (“GIC”) $ — $ 64 $ — $ 64 Total assets $ — $ 64 $ — $ 64 Fair Value Measurements as of December 31, 2020 Quoted Prices in Active Markets using Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Assets Guaranteed Investment Certificates (“GIC”) $ — $ 64 $ — $ 64 Restricted cash 83 — — 83 Total assets $ 83 $ 64 $ — $ 147 Liabilities Contingent earn-out consideration — — 147 147 Total liabilities $ — $ — $ 147 $ 147 The earn-out liability was measured using discounted cash flow techniques, with the expected cash outflows estimated based on the assessed probability of the acquired business achieving the revenue metrics required for payment. Expected future revenues of the acquired business and the associated estimate of probability are not two The following table provides a roll forward of the aggregate fair values of the earn-out liability as of December 31, 2021 3 Beginning balance $ 655 Payments (799 ) Change in value 291 December 31, 2020 147 Payments (147 ) Change in value - December 31, 2021 $ - In addition to earn-out contingent liability disclosed above, the Company had an annual installment payable of $250. On September 25, 2020, January 26, 2018, December 1, 2020 January 4, 2021.

Note 6 - Accounts Receivable

Note 6 - Accounts Receivable	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Trade and Financing Receivables [Text Block]	6. The Company’s products may A financing receivable is a contractual right to receive money, on demand or on fixed or determinable dates, that is recognized as an asset on the Company’s consolidated balance sheets. The Company’s financing receivables, consisting of its sales-type leases, totale d $53,887 December 31, 2021 2020 T he Company performed an assessment of the allowance for doubtful accounts as of December 31, 2021 2020 . Based upon such assessment, the Company recorded an allowance for doubtful totaling $11,997 and $18,490 as of December 31, 2021 2020 , respectively. A summary of the Company’s accounts receivables is presented as follows: As of December 31, 2021 2020 Gross accounts receivable $ 86,625 $ 92,402 Unearned income (4,033 ) (3,728 ) Allowance for doubtful accounts (11,997 ) (18,490 ) $ 70,595 $ 70,184 Reported as: Current trade receivables $ 46,918 $ 52,764 Current unearned interest income (2,678 ) (1,950 ) Long-term trade receivables 27,710 21,148 Long-term unearned interest income (1,355 ) (1,778 ) $ 70,595 $ 70,184 Current subscription contracts are reported as part of accounts receivable. The following are the contractual commitments, net of allowance for doubtful accounts, to be received by the Company over the next 5 December 31, Total 2022 2023 2024 2025 2026 Current financing receivables, net of allowance of $ 6,601 $ 26,177 $ 26,177 $ — $ — $ — $ — Long-term financing receivables, net of allowance of $ 167 27,710 — 19,256 8,262 192 — $ 53,887 $ 26,177 $ 19,256 $ 8,262 $ 192 $ — Accounts receivable do not not may The allowance for doubtful accounts consisted of the following activity for years ended December 31, 2021 2020: As of December 31, 2021 2020 Balance at beginning of year $ 18,490 $ 10,494 Write-offs (6,230 ) (6,536 ) (Recovery) provision (263 ) 15,212 Sale of subsidiaries — (680 ) Balance at end of year $ 11,997 $ 18,490

Note 7 - Select Balance Sheet a

Note 7 - Select Balance Sheet and Statement of Operations Information	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Balance Sheet and Income Statement Disclosures [Text Block]	7. Inventory Inventory consists of the following: December 31, 2021 2020 Raw materials $ 2,368 $ 838 Work-in-progress 1,649 1,232 Finished goods 16,526 15,689 Total inventory $ 20,543 $ 17,759 Additions to inventory are primarily comprised of newly produced units and applicators, refurbishment cost from demonstration units and used equipment which were reacquired during the year from upgraded sales. The Company expensed $ 26,047 ( 2020 The Company provides for excess and obsolete inventories when conditions indicate that the inventory cost is not December 31, 2021 1,456 2020 Property and Equipment, Net Property and equipment, net consist of the following: December 31, Useful Lives (in years) 2021 2020 Lab equipment tooling and molds 4 – 10 $ 8,194 $ 8,053 Office furniture and equipment 6 – 10 1,743 1,760 Leasehold improvements up to 10 1,839 1,838 Computers and software 3 1,939 1,815 Vehicles 5 – 7 37 12 Demo units 5 114 — Total property and equipment 13,866 13,478 Less: Accumulated depreciation (11,197 ) (9,939 ) Total property and equipment, net $ 2,669 $ 3,539 Depreciation expense amounted to $ 1,381 December 31, 2021 2020 Other Current Assets December 31, 2021 2020 Government remittances (1) $ 1,322 $ 1,009 Consideration receivable from subsidiaries sale 1,405 2,580 Deferred financing costs 223 1,063 Sundry assets and miscellaneous 808 1,022 Total other current assets $ 3,758 $ 5,674 ( 1 Government remittances are receivables from the local tax authorities for refund of sales taxes and income taxes. Accrued Expenses and Other Current Liabilities December 31, 2021 2020 Payroll and related expense $ 1,770 $ 1,312 Accrued expenses 6,584 8,582 Commission accrual 4,529 2,827 Sales and consumption taxes 6,629 7,532 Total accrued expenses and other current liabilities $ 19,512 $ 20,253 Warranty Accrual The following table provides the details of the change in the Company’s warranty accrual: December 31, 2021 2020 Balance as of the beginning of the year $ 1,639 $ 1,977 Warranties issued during the year 1,231 761 Warranty costs incurred during the year (1,117 ) (1,099 ) Balance at the end of the year $ 1,753 $ 1,639 Current 1,245 1,106 Long-term 508 533 Total $ 1,753 $ 1,639 Finance Expenses The following table provides the details of the Company’s finance expenses: December 31, 2021 2020 Interest expense $ 3,720 $ 7,615 Accretion on long-term debt and amortization of fees 1,235 728 Total finance expenses $ 4,955 $ 8,343

Note 8 - Intangible Assets and

Note 8 - Intangible Assets and Goodwill	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Goodwill and Intangible Assets Disclosure [Text Block]	8. In November 2019, The carrying values of goodwill and indefinite-life intangible assets are subject to annual impairment assessment as of the last day of each fiscal year. Between annual assessments, impairment review may 19 first three 2020, 19 March 31, 2020. The Company has one March 31, 2020, March 31, 2020, December 31, 2021 2020 Intangible assets net of accumulated amortization were as follows: At December 31, 2021 Gross Amount Accumulated Amortization Net Amount Customer relationships $ 1,400 $ (336 ) $ 1,064 Brand 2,500 (803 ) 1,697 Technology 16,900 (6,103 ) 10,797 Supplier agreement 3,000 (1,165 ) 1,835 Total intangible assets $ 23,800 $ (8,407 ) $ 15,393 At December 31, 2020 Gross Amount Accumulated Amortization Net Amount Customer relationships $ 1,400 $ (242 ) $ 1,158 Brand 2,500 (540 ) 1,960 Technology 16,900 (3,286 ) 13,614 Supplier agreement 3,000 (867 ) 2,133 Total intangible assets $ 23,800 $ (4,935 ) $ 18,865 For the years ended December 31, 2021 2020, Estimated amortization expense for the next five Years ending December 31, 2022 $ 3,473 2023 3,473 2024 3,473 2025 3,004 2026 657 Thereafter 1,313 Total $ 15,393

Note 9 - Commitments and Contin

Note 9 - Commitments and Contingencies	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	9. Operating Leases The Company and its subsidiaries have various operating lease agreements, which expire on various dates. The Company recognizes rent expense on a straight-line basis over the non-cancellable lease period and records the difference between cash rent payments and the recognition of rent expense as a deferred rent liability. When leases contain escalation clauses, rent abatements and/or concessions, such as rent holidays and landlord or tenant incentives or allowances, the Company applies them in the determination of straight-line rent expense over the lease period. Aggregate future minimum lease payments, and service and purchase commitments with manufacturers as of December 31, 2021 Years ending December 31, Office Lease Purchase and Service Commitments Total 2022 $ 1,404 $ 18,551 $ 19,955 2023 1,253 — 1,253 2024 1,108 — 1,108 2025 1,053 — 1,053 2026 1,036 — 1,036 Thereafter 1,240 — 1,240 Total $ 7,094 $ 18,551 $ 25,645 The total rent expense for all operating leases for the years ended December 31, 2021 2020 2,187 a Commitments As of December 31, 2021 mount of $17,598 . In addition, as of December 31, 2021 , the Company had $6,352 of open purchase orders that can be cancelled with 270 On March 25, 2021, four seven Legal Proceedings Purported Shareholder Class Actions In 2018 2019, four No. 18CIV02609, No. 19CIV08173 11, 12 2 15 1933 No. 5:18 03712 No. 5:18 03883 11 15 1933 September 1, 2017 October 13, 2017 not In the State Actions, Restoration Robotics, Inc., along with the other defendants, successfully demurred to the initial Wong complaint for failure to state a claim and secured a stay of both cases based on the forum selection clause contained in its Amended and Restated Certificate of Incorporation, which designates the federal district courts as the exclusive forums for claims arising under the 1933 December 19, 2018, December 10, 2019. January 17, 2020, September 1, 2017 October 13, 2017 not February 24, 2020, March 18, 2020, March 30, 2020, June 12, 2020. September 1, 2020, September 22, 2020, November 23, 2020, May 27, 2021, No. A161489 1st 2 August 27, 2021, October 6, 2021. In the Federal Actions, the complaints alleged that Restoration Robotics’ Registration Statement filed with the SEC on September 1, 2017 October 13, 2017 not February 22, 2021, July 29, 2021, September 2, 2021. September 9, 2021. July 11, 2019, No. 5:19 03997 14 1934 2018 August 21, 2019, June 21, 2021, Administrative Investigation Case The Company’s Chinese subsidiary, Venus Concept China, imports and sells registered medical devices and unregistered non-medical devices in the People’s Republic of China (“PRC”). One of its unregistered products was the subject of inquiries from two January 2019, June 12, 2019, March 4, 2021, March 8, 2021. March 19, 2021, may not

Note 10 - Main Street Term Loan

Note 10 - Main Street Term Loan	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Debt Disclosure [Text Block]	10. On December 8, 2020, December 9, 2020, five 30 December 8, 2023 December 8, 2024, fifteen December 8, 2025. may As of December 31, 2021 December 31, 2020, The scheduled payments on the outstanding borrowings as of December 31, 2021 As of December 31, 2021 2022 $ 1,622 2023 9,357 2024 7,957 2025 38,429 Total $ 57,365

Note 11 - Madryn Long-term Debt

Note 11 - Madryn Long-term Debt and Convertible Notes	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Debt Disclosure [Text Block]	10. On December 8, 2020, December 9, 2020, five 30 December 8, 2023 December 8, 2024, fifteen December 8, 2025. may As of December 31, 2021 December 31, 2020, The scheduled payments on the outstanding borrowings as of December 31, 2021 As of December 31, 2021 2022 $ 1,622 2023 9,357 2024 7,957 2025 38,429 Total $ 57,365
Madryn Long Term Debt and Convertible Notes [Member]
Notes to Financial Statements
Debt Disclosure [Text Block]	11. On October 11, 2016, four September 30, 2020, 1 2 24th September 30, 2022, In connection with the Merger, the Company entered into an amendment to the Madryn Credit Agreement, dated as of November 7, 2019, ( October 11, 2016, ( August 14, 2018, The Company had the option of settling the paid in kind (“PIK ”) interest in cash or adding the owed interest to the principal amount of the loan. On April 29, 2020, January 1, 2020 April 29, 2020 ( On June 30, 2020, June 30, 2020, ( four June 30, 2020, four September 30, 2020, June 1, 2020 September 30, 2020 June 1, 2020 September 30, 2020. On September 30, 2020, fifty July 1, 2020 September 30, 2020 ( fifty On December 9, 2020, 10 December 9, 2020 The Notes will accrue interest at a rate of 8.0% per annum from the date of original issuance of the Notes to the third December 31, 2020. December 9, 2025 first Notes are secured by substantially all of the assets of Venus Concept Inc. and its subsidiaries party to the Madryn Security Agreement. The Company’s obligations under the Notes and the security interests and liens created by the Madryn Security Agreement are subordinated to the Company’s indebtedness owing to CNB (including, but not 11 December 31, 2021 815 10 15 not 815, two December 31, 2021 December 31, 2020, December 31, 2021 December 31, 2020. The scheduled payments on the outstanding borrowings as of December 31, 2021 As of December 31, 2021 2022 $ 2,165 2023 2,131 2024 1,628 2025 28,217 Total $ 34,141 For the years ended December 31, 2021 2020, not

Note 12 - Credit Facility

Note 12 - Credit Facility	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Credit Facility Disclosure [Text Block]	12. CREDIT FACILITY On August 29, 2018, March 20, 2020, December 9, 2020 August 26, 2021 ( August 29, 2018, March 20, 2020, December 9, 2020 August 26, 2021 ( March 20, 2020, December 9, 2020 August 26, 2021, The CNB Loan Agreement contains various covenants that limit the Company’s ability to engage in specified types of transactions. Subject to limited exceptions, these covenants limit the Company’s ability, without CNB’s consent, to, among other things, sell, lease, transfer, exclusively license or dispose of the Company’s assets, incur, create or permit to exist additional indebtedness, or liens, to make dividends and certain other restricted payments, and to make certain changes to its management and/or ownership structure. The CNB Loan Agreement also contains a covenant requiring that a minimum of $23,000 in cash be held in a deposit account maintained with CNB for one first December 2021. January 25, February 25 March 25, 2021. On August 26, 2021, 30 December 10, 2021, As of December 31, 2021 December 31, 2020 r the MSLP Loan (see Note 10 In connection with the Amended CNB Loan Agreement, the Company, Venus USA and Venus Canada issued a promissory note dated August 26, 2021, July 24, 2023 August 26, 2021 (

Note 13 - Government Assistance

Note 13 - Government Assistance Programs	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Government Assistance Programs [Text Block]	13. Venus Concept Inc. and Venus USA, received funding in the total amount of $4,048 in connection with two 7 1953, Venus Concept Inc. entered into a U.S. Small Business Administration Note dated as of April 21, 2020 April 29, 2020 ( 1% two April 2022. The Venus Concept PPP Loan contains certain covenants which, among other things, restrict the Company’s use of the proceeds of the PPP Loan to the payment of payroll costs, interest on mortgage obligations, rent obligations and utility expenses, require compliance with all other loans or other agreements with any creditor of the Company, to the extent that a default under any loan or other agreement would materially affect the Company’s ability to repay its PPP Loan and limit the Company’s ability to make certain changes to its ownership structure. Venus USA entered into a U.S. Small Business Administration Note dated as of April 15, 2020 April 20, 2020 ( Under certain circumstances, all or a portion of the PPP Loans may Under the CNB Loan Agreement and the MSLP Loan Agreement, each PPP Loan is permitted to be incurred by Venus Concept Inc. and Venus USA as long as certain conditions remain satisfied. If Venus Concept Inc. and/or Venus USA defaults on the respective PPP Loan (i) events of default will occur under the CNB Loan Agreement and the MSLP Loan Agreement and (ii) Venus Concept Inc. and Venus USA may As of December 31, 2021 $543 December 31, 2020). In 2020,

Note 14 - Common Stock Reserved

Note 14 - Common Stock Reserved for Issuance	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Common Stock Reserved For Issuance [Text Block]	14. The Company is required to reserve and keep available out of its authorized but unissued shares of common stock a number of shares sufficient to affect the exercise of all options granted and available for grant under the incentive plans and warrants to purchase common stock. December 31, 2021 December 31, 2020 Outstanding common stock warrants 15,928,867 16,290,067 Outstanding stock options 5,977,179 4,433,392 Shares reserved for future option grants 589,064 262,622 Shares reserved for Lincoln Park 5,222,867 5,222,867 Shares reserved for Madryn Noteholders 8,213,880 8,213,880 Total common stock reserved for issuance 35,931,857 34,422,828

Note 15 - Stockholders Equity

Note 15 - Stockholders Equity	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	15. Common Stock The Company’s common stock confers upon its holders the following rights: • The right to participate and vote in the Company’s stockholder meetings, whether annual or special. Each share will entitle its holder, when attending and participating in the voting in person or via proxy, to one • The right to a share in the distribution of dividends, whether in cash or in the form of bonus shares, the distribution of assets or any other distribution pro rata to the par value of the shares held by them; and • The right to a share in the distribution of the Company’s excess assets upon liquidation pro rata to the par value of the shares held by them. Preferred Stock issued in December 2021 As noted in Note 1 December 2021, December 14, 2021. • Voting Rights. no • Liquidation. not • Conversion . 1:1, not • Dividends. • Redemption not • Maturity. Upon issuance, the effective conversion price of the Preferred Stock of $1.25 per share was lower than the market price of the Company’s common stock on the date of issuance of the Preferred Stock of $1.29 per share; as a result, the Company recorded the beneficial conversion feature of $152 in accumulated paid in capital ("APIC"). Because the Preferred Stock is perpetual, it is carried at the amount recorded at inception. Upon conversion of the Preferred Stock, the beneficial conversion feature will be accounted for as deemed dividend. The Company evaluated the Preferred Stock for liability or equity classification in accordance with the provisions of ASC 480, not not not not 480 Since the Preferred Stock was sold as a unit with the common stock, the proceeds received were allocated to each instrument on a relative fair value basis. Total net proceeds of $16,740 reduced by $152 of the beneficial conversion feature were allocated as follows: $4,514 to the Preferred Stock and $12,074 to shares of common stock. The Preferred Stock and common stock issued in the 2021 Preferred Stock issued in March 2020 In March 2020, March 18, 2020. • Voting Rights. no • Liquidation. not • Conversion. 1:10, not • Dividends. • Redemption. not • Maturity. Upon issuance, the effective conversion price of the Series A Preferred Stock of $1.93 per share was lower than the market price of the Company’s common stock on the date of issuance of the Series A Preferred Stock of $2.47 per share; as a result, the Company recorded the beneficial conversion feature of $3,564 in APIC. Because the Series A Preferred Stock is perpetual, it is carried at the amount recorded at inception. Subsequently, upon conversion of the Series A Preferred Stock, the beneficial conversion feature was accounted for as deemed dividend as disclosed below. The Company evaluated the Series A Preferred Stock for liability or equity classification in accordance with the provisions of ASC 480, not not not not 480 Since Series A Preferred Stock was sold as a unit with warrants, the proceeds received were allocated to each instrument on a relative fair value basis as it is described below. All outstanding shares of Series A Preferred Stock were converted into shares of common stock on June 16, 2020, 2020 In March 2020, 2020 2020 five 2020 480, not not 2020 not 2020 not 2020 Total net proceeds of $20,300 reduced by $3,564 of the beneficial conversion feature were allocated as follows: $8,063 to Series A Preferred Stock, $4,052 to shares of common stock and $4,621 to the 2020 2020 Conversion of Series A Preferred Stock shares On June 16, 2020, 470 20 40 1, December 2020 In December 2020, December 2020 December 2020 five December 2020 480, not not December 2020 not December 2020 not December 2020 2010 In November 2010, “2010 2010 seven ten November 2017 2010 not December 31, 2021 December 31, 2020 2010 December 31, 2020 2019 Incentive Award Plan The 2019 “2019 2017 September 12, 2017 September 14, 2017. 2017 October 4, 2019. Under the 2019 2019 December 31, 2021 2019 December 31, 2020 2019 first 2020 2029 four The Company recognized stock-based compensation for its employees and non-employees in the accompanying consolidated statements of operations as follows: Year Ended December 31, 2021 2020 Cost of sales $ 31 $ 25 Selling and marketing 848 872 General and administrative 1,084 1,151 Research and development 105 90 Total stock-based compensation $ 2,068 $ 2,138 Stock Options The fair value of each option is estimated at the date of grant using the Black-Scholes option pricing formula with the following assumptions : Year Ended December 31, 2021 2020 Expected term (in years) 6.00 6.00 - 6.54 Risk-free interest rate 0.98-1.36 % 0.38 - 1.50 % Expected volatility 44.26 % 42.83 % Expected dividend rate 0 % 0 % Expected Term Volatility not Risk-Free Interest Rate zero Dividend Rate not Fair Value of Common Stock The following table summarizes stock option activity under the Company’s stock option plan: Number of Shares Weighted- Average Exercise Price per Share, $ Weighted- Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding – January 1, 2021 4,433,392 $ 4.59 6.20 $ 247 Options granted 2,664,500 2.20 - Options exercised (261,836 ) 2.34 92 Options forfeited/cancelled (858,877 ) 4.21 - Outstanding - December 31, 2021 5,977,179 $ 3.72 7.20 $ 136 Exercisable – December 31, 2021 2,907,668 $ 4.52 5.27 $ 136 Expected to vest – after December 31, 2021 3,069,511 $ 2.97 9.03 $ - The following tables summarize information about share options outstanding and exercisable on December 31, 2021 Options Outstanding Options Exercisable Exercise Price Range Number Weighted average remaining contractual term (years) Weighted average Exercise Price Options exercisable Weighted average remaining contractual term (years) Weighted average Exercise Price $1.35 - $3.64 4,675,428 7.46 $ 2.67 1,896,935 4.96 $ 2.92 $4.26 - $7.95 1,250,316 6.32 6.82 965,929 5.88 6.69 $12.45 - $26.10 31,156 6.75 18.02 24,558 6.71 18.19 $27.00 - $33.00 11,900 3.00 27.62 11,882 2.99 27.62 $36.00 - $94.65 8,379 5.69 45.42 8,364 5.69 45.39 5,977,179 7.20 $ 3.72 2,907,668 5.27 $ 4.52 The aggregate intrinsic value of options is calculated as the difference between the exercise price of the stock options and the fair value of the Company’s common stock for those options that had exercise prices lower than the fair value of the Company’s common stock. The total intrinsic value of options exercised were $92 and $464 for the years ended December 31, 2021 2020 The weighted-average grant date fair value of options granted was $2.20 and $4.17 per share for the years ended December 31, 2021 2020

Note 16 - Income Taxes

Note 16 - Income Taxes	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Income Tax Disclosure [Text Block]	16. The geographical breakdown of loss before income taxes is as follows: Year Ended December 31, 2021 2020 United States $ (12,260 ) $ (63,259 ) Other jurisdictions (10,588 ) (18,378 ) Loss before income taxes $ (22,848 ) $ (81,637 ) The components of the (benefit) provision for income taxes are as follows: Year Ended December 31, 2021 2020 Current tax (benefit) provision: Federal $ — $ — Foreign (542 ) 1,619 Total current tax (benefit) provision (542 ) 1,619 Deferred tax benefit: Federal — — Foreign (165 ) (438 ) Total deferred tax benefit $ (165 ) $ (438 ) Total (benefit) provision for income taxes $ (707 ) $ 1,181 Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided when it is more likely than not not December 31, 2021 December 31, 2020) not no December 31, 2021 2020 The Company’s effective tax rate substantially differed from the federal statutory tax rate primarily due to the change in the valuation allowance. The reconciliation between income taxes computed at the federal statutory income tax rate and the provision for income taxes is as follows: Year Ended December 31, 2021 2020 Loss before income taxes $ (22,848 ) $ (81,637 ) Theoretical tax benefit at the statutory rate ( 21.0 21.0 (4,798 ) (17,144 ) Differences in jurisdictional tax rates (350 ) (2,817 ) Valuation allowance 5,755 12,416 Non-deductible expenses (266 ) 8,080 Other (1,048 ) 646 Total income tax (benefit) provision (707 ) 1,181 Net loss $ (22,141 ) $ (82,818 ) The components of the deferred tax assets and deferred tax liabilities are as follows: December 31, 2021 2020 Deferred tax assets: Property and equipment $ 668 $ 735 Deferred revenue 647 2,065 Allowance for doubtful accounts 3,133 2,670 Intangible assets (1,543 ) (2,554 ) Non-deductible expenses 8,694 8,350 Warranty and other reserves 1,159 729 Other 610 114 Loss carryforwards 38,353 71,362 Valuation allowance (51,437 ) (82,587 ) Total deferred tax assets $ 284 $ 884 Deferred tax liabilities: Deferred revenue $ 46 $ 811 Total deferred tax liabilities $ 46 $ 811 As of December 31, 2021 2020 not 2022 $nil, December 31, 2021 2025 not no The Company may not 50% 740 Utilization of the research and development credits carryforwards may not may The Company files income tax returns in the United States and in various state jurisdictions with varying statutes of limitations. Tax years 2015 2021 Uncertain Tax Positions The activity related to gross amount of unrecognized tax benefits is as follows: Year Ended December 31, 2021 2020 Balance as of the beginning of the year $ 1,584 $ 1,467 (Reduction) increases related to tax positions in prior period (1,548 ) 57 Increases related to tax positions taken during the current period — 60 Balance at the end of the year $ 36 $ 1,584 These amounts are related to certain deferred tax assets with a corresponding valuation allowance. If recognized, the impact on the Company’s effective tax rate would not not twelve The Company recognizes interest and penalties related to unrecognized tax benefits in the provision for income taxes in the accompanying consolidated statement of operations. Accrued interest and penalties, if applicable, are included in accrued expenses and other current liabilities in the consolidated balance sheets. For the years ended December 31, 2021 2020 not The activity related to the tax effected amount of the recognized tax position as follows: Year Ended December 31, 2021 2020 Balance as of the beginning of the year $ (478 ) $ - Increases related to tax positions in prior period — (369 ) Increase related to tax position taken during the current period (49 ) — Increase related to interest expense (36 ) (109 ) Balance at the end of the year $ (563 ) $ (478 ) Additional current tax expense has been booked including interest and penalties relating to Venus Concept Australia Pty Ltd. for its historical tax return filing positions, which may not twelve

Note 17 - Segment and Geographi

Note 17 - Segment and Geographic Information	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	17. GEOGRAPHIC INFORMATION Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (CODM) in deciding how to allocate resources to an individual segment and in assessing performance. The Company's CODM is its Chief Executive Officer. The Company has determined it operates in a single one not Revenue by geographic location, which is based on the product shipped to location, is summarized as follows: Year Ended December 31, 2021 2020 United States $ 53,520 $ 33,987 International 52,102 44,027 Total revenue $ 105,622 $ 78,014 As of December 31, 2021 December 31, 2020 Revenue by type is a key indicator for providing management with an understanding of the Company’s financial performance, which is organized into four 1. Lease revenue - includes all system sales with typical lease terms of 36 months. 2. System revenue – includes all systems sales with payment terms within 12 months. 3. Product revenue – includes skincare, hair and other consumables payable upon receipt. 4. Service revenue - includes NeoGraft technician services, ad agency services and extended warranty sales. The following table presents revenue by type: Year Ended December 31, 2021 2020 Lease revenue $ 45,094 $ 33,428 System revenue 43,106 28,957 Product revenue 13,230 10,858 Service revenue 4,192 4,771 Total revenue $ 105,622 $ 78,014

Note 18 - Related Party Transac

Note 18 - Related Party Transactions	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	18. All amounts were at recorded at the exchange amount, which is the amount established and agreed to by the related parties. The following are transactions between the Company and parties related through employment. Sales and Purchases of Securities On December 15, 2021, 2021 1 1:1 2021 2021 On March 19, 2020, 2020 2020 2020 Registration Rights Agreements On December 15, 2021 2021 On March 18, 2020, 2020 Declaration and Distribution of Dividends from Venus Concept Singapore Pte. Ltd On March 5, 2020, forty-five Distribution agreements On January 1, 2018, December 31, 2021 2020 In 2020, January 1, 2021, December 31, 2021 2020

Note 19 - Subsequent Events

Note 19 - Subsequent Events	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Subsequent Events [Text Block]	19. On March 24, 2022, f 356,250 2019

Significant Accounting Policies

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (U.S. GAAP).
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The accompanying consolidated financial statements include the accounts of Venus Concept Inc. and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated on consolidation. Where the Company does not 100%
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates and assumptions made in the accompanying consolidated financial statements include, but are not The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID- 19 December 31, 2021 not 19 $nil December 31, 2021 December 31, 2020 $27,450 (Note 8 March 31, 2020.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	Foreign Currency The consolidated financial statements are presented in U.S. dollars. Amounts reported in thousands within this report are computed based on the amounts in dollars. As a result, the sum of the components reported in thousands may not may not All exchange gains and losses from remeasurement of monetary balance sheet items resulting from transactions in non-functional currencies are recorded in the consolidated statements of operations as they arise. In respect of transactions denominated in currencies other than the Company and its subsidiaries’ functional currencies, the monetary assets and liabilities are remeasured at the period end rates. Revenue and expenses are remeasured at rates of exchange prevailing on the transaction dates. All of the exchange gains or losses resulting from these transactions are recognized in the consolidated statements of operations.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]	Restricted Cash As of December 31, 2021 2020 $nil
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentration of Credit Risk Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents, accounts receivable and long-term receivables. The Company’s cash and cash equivalents are invested primarily in deposits with major banks worldwide, as such minimal credit risk exists with respect to such investments. The Company’s trade receivables are derived from global sales to customers. An allowance for doubtful accounts is provided with respect to all balances for which collection is deemed to be doubtful.
Risk and Uncertainties [Policy Text Block]	Risks and Uncertainties The Company has considered the impact of COVID- 19 19 2020, December 31, 2021 may not Besides COVID- 19, not may may The Company has borrowings with interest rates that are subject to fluctuations as charged by the lender. The Company does not December 31, 2021 2020
Concentration of Customers [Policy Text Block]	Concentration of Customers For the years ended December 31, 2021 2020 10% 10%
Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]	Allowance for Doubtful Accounts Trade accounts receivable do not not may December 31, 2021 2020
Inventory, Policy [Policy Text Block]	Inventory Inventories are stated at the lower of cost or net realizable value and include raw materials, work in progress and finished goods. Cost is determined as follows: Raw Materials and Work in Progress (“WIP”) – Cost is determined on a standard cost basis utilizing the weighted average cost of historical purchases, which approximates actual cost. The cost of WIP and finished goods includes the cost of raw materials and the applicable share of the cost of labor and fixed and variable production overheads. The Company regularly evaluates the value of inventory based on a combination of factors including the following: historical usage rates, product end of life dates, technological obsolescence and product introductions. The Company includes demonstration units within inventories. Proceeds from the sale of demonstration units are recorded as revenue.
Receivable [Policy Text Block]	Long-term Receivables Long-term receivables relate to the Company’s subscription revenue or contracts which stipulate payment terms which exceed one 2021 2020 Deferred revenues represent payments received prior to the income being earned. Once the equipment has been delivered or the services have been rendered, these amounts are recognized in income.
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, which is between three ten
Intangible Assets, Finite-Lived, Policy [Policy Text Block]	Intangible Assets Intangible assets consist of customer relationships, brand, technology and supplier agreement. Intangible assets are stated at cost less accumulated amortization. Amortization is computed using the straight-line method over the estimated useful lives of the respective assets, which range from approximately six fifteen The useful lives of intangible assets are based on the Company’s assessment of various factors impacting estimated cash flows, such as the product’s position in its lifecycle, the existence or absence of like products in the market, various other competitive and regulatory issues, and contractual terms.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of Long-Lived Assets The Company accounts for the impairment of long-lived assets in accordance with FASB, Accounting Standards Codification (“ASC”) 360 10, may not December 31, 2021 2020
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]	Goodwill Goodwill represents the excess of the purchase price of the business acquired over the fair value of the net identifiable assets of an acquired business. The Company allocates goodwill to reporting units at the time of acquisition or when there is a change in the reporting structure and bases that allocation on which reporting units will benefit from the acquired assets and liabilities. Reporting units are defined as operating segments or one Goodwill is not may not may 19 first three 2020, 19 March 31, 2020. The Company has one reporting unit and the reporting unit’s carrying value was compared to its estimated fair value. As of March 31, 2020, March 31, 2020, December 31, 2021 2020 no
Debt, Policy [Policy Text Block]	Debt Issuance Costs Costs related to the issuance of debt are presented as a direct deduction to the carrying value of the debt and are amortized to accretion expenses using the effective interest rate method over the term of the related debt.
Derivatives, Policy [Policy Text Block]	Derivatives The Company reviews the terms of convertible notes, equity instruments and other financing arrangements to determine whether there are embedded derivative instruments, including embedded conversion options that are required to be bifurcated and accounted for separately as a derivative financial instrument. Derivative financial instruments are initially measured at their fair value. Derivative financial instruments that are accounted for as liabilities, are initially recorded at fair value and then re-valued at each reporting date, with changes in the fair value recognized in the consolidated statements of operations.
Revenue from Contract with Customer [Policy Text Block]	Revenue Recognition The Company adopted Accounting Standards Codification (“ASC”) 606 606” January 1, 2019 not 606 The Company generates revenue from ( 1 2 3 2two5 fourth 2021. 2two5 third 2020. 2two5 not 2020 Many of the Company’s products are sold under subscription contracts with control passing to the customer at the earlier of the end of the term and when the payment is received in full. The subscription contracts include an initial deposit followed by monthly installments typically over a period of 36 months. In accordance with ASC 840 840” The Company recognizes revenues on other products and services in accordance with ASC 606. five 1 2 3 4 5 The Company does not
Cost of Goods and Service [Policy Text Block]	Cost of Goods For subscription sales (qualifying as sales-type lease arrangements) and product sales, the costs are recognized upon shipment to the customer or distributor.
Advertising Cost [Policy Text Block]	Advertising Costs The cost of advertising and media is expensed as incurred. For the years ended December 31, 2021 2020
Research and Development Expense, Policy [Policy Text Block]	Research and Development Research and development costs are charged to operations as incurred. Major components of research and development expenses consist of personnel costs, including salaries and benefits, hardware and software research and development costs, regulatory affairs, and clinical costs.
Standard Product Warranty, Policy [Policy Text Block]	Warranty The Company provides a standard warranty against defects for all of its systems. The warranty period begins upon shipment and is typically for a period between one three The Company records a liability for accrued warranty costs at the time of sale of a system, which consists of the warranty on products sold based on historical warranty costs and management’s estimates. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts thereof as necessary. The Company also provides an extended warranty service. Extended warranty can be purchased at any time after the purchase of a system and prior to the expiration of the standard warranty provided with the sale of the system. Extended warranty services include standard warranty services. The Company recognizes the revenue from the sale of an extended warranty over the period of the extended warranty and accounts it for separately from the standard warranty.
Income Tax, Policy [Policy Text Block]	Income Taxes The Company follows the deferred income taxes method of accounting for income taxes. Under this method, deferred income taxes are recognized for the future tax consequences attributable to differences between the financial statement carrying values of accounts and their respective income tax basis. Deferred income tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the years during which the temporary differences are expected to be realized or settled. The effect on deferred income tax assets and liabilities of a change in tax rates is included in income in the period that includes the enactment date. The Company establishes valuation allowances when necessary to reduce deferred tax assets to the amounts that are more likely than not not” not not” not
Income Tax Uncertainties, Policy [Policy Text Block]	Uncertain Tax Positions The Company recognizes the effect of income tax positions only if those positions are more likely than not first not second 50% The Company considers many factors when evaluating and estimating its tax positions and tax benefits, which may
Share-based Payment Arrangement [Policy Text Block]	Stock-Based Compensation The Company accounts for stock-based compensation in accordance with ASC 718, 718” 718 The fair value of stock options (“options”) on the grant date is estimated using the Black-Scholes option-pricing model using the single-option approach. The Black-Scholes option pricing model requires the use of highly subjective and complex assumptions, including the option’s expected term and the price volatility of the underlying stock, to determine the fair value of the award. The Company recognizes compensation expenses for the value of its awards granted based on the straight-line method over the requisite service period of each of the awards. The Company has made a policy choice to account for forfeitures when they occur.
Earnings Per Share, Policy [Policy Text Block]	Net Loss Per Share The Company computes net (loss) income per share in accordance with ASC Topic 260, 260” two two not Diluted net (loss) income per share is the same as basic net (loss) income per share for the periods in which the Company had a net loss because the inclusion of outstanding common stock equivalents would be anti-dilutive.
JOBS Act Accounting Election [Policy Text Block]	JOBS Act Accounting Election The Company is an emerging growth company, as defined in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it is (i) no may not
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued Accounting Standards Not In April 2020, 842 840: 19 19. 19 not In March 2020, 2020 04 848 2021, March 12, 2020 December 31, 2022. may no December 31, 2022. January 2021, may 848. In February 2020, 2020 02 326 842 326 842. 326, 326 January 1, 2023, In December 2019, 2019 12 740 first 2022,

Note 3 - Net Loss Per Share (Ta

Note 3 - Net Loss Per Share (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	For the year ended December 31, 2021 2020 Numerator: Net loss $ (22,141 ) $ (82,818 ) Net loss allocated to stockholders of the Company $ (23,013 ) $ (85,270 ) Denominator: Weighted-average shares of common stock outstanding used in computing net loss per share, basic and diluted 54,466 36,626 Net loss per share: Basic and diluted $ (0.42 ) $ (2.33 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	December 31, 2021 2020 Options to purchase common stock 5,977,179 4,433,392 Warrants for common stock 15,928,867 16,290,067 Total potential dilutive shares 21,906,046 20,723,459

Note 5 - Fair Value Measureme_2

Note 5 - Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Fair Value, by Balance Sheet Grouping [Table Text Block]	Fair Value Measurements as of December 31, 2021 Quoted Prices in Active Markets using Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Assets Guaranteed Investment Certificates (“GIC”) $ — $ 64 $ — $ 64 Total assets $ — $ 64 $ — $ 64 Fair Value Measurements as of December 31, 2020 Quoted Prices in Active Markets using Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Assets Guaranteed Investment Certificates (“GIC”) $ — $ 64 $ — $ 64 Restricted cash 83 — — 83 Total assets $ 83 $ 64 $ — $ 147 Liabilities Contingent earn-out consideration — — 147 147 Total liabilities $ — $ — $ 147 $ 147
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Beginning balance $ 655 Payments (799 ) Change in value 291 December 31, 2020 147 Payments (147 ) Change in value - December 31, 2021 $ -

Note 6 - Accounts Receivable (T

Note 6 - Accounts Receivable (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	As of December 31, 2021 2020 Gross accounts receivable $ 86,625 $ 92,402 Unearned income (4,033 ) (3,728 ) Allowance for doubtful accounts (11,997 ) (18,490 ) $ 70,595 $ 70,184 Reported as: Current trade receivables $ 46,918 $ 52,764 Current unearned interest income (2,678 ) (1,950 ) Long-term trade receivables 27,710 21,148 Long-term unearned interest income (1,355 ) (1,778 ) $ 70,595 $ 70,184
Contractual Commitments, Net of Allowance For Doubtful Accounts To Be Received Maturity [Table Text Block]	December 31, Total 2022 2023 2024 2025 2026 Current financing receivables, net of allowance of $ 6,601 $ 26,177 $ 26,177 $ — $ — $ — $ — Long-term financing receivables, net of allowance of $ 167 27,710 — 19,256 8,262 192 — $ 53,887 $ 26,177 $ 19,256 $ 8,262 $ 192 $ —
Accounts Receivable, Allowance for Credit Loss [Table Text Block]	As of December 31, 2021 2020 Balance at beginning of year $ 18,490 $ 10,494 Write-offs (6,230 ) (6,536 ) (Recovery) provision (263 ) 15,212 Sale of subsidiaries — (680 ) Balance at end of year $ 11,997 $ 18,490

Note 7 - Select Balance Sheet_2

Note 7 - Select Balance Sheet and Statement of Operations Information (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Schedule of Inventory, Current [Table Text Block]	December 31, 2021 2020 Raw materials $ 2,368 $ 838 Work-in-progress 1,649 1,232 Finished goods 16,526 15,689 Total inventory $ 20,543 $ 17,759
Property, Plant and Equipment [Table Text Block]	December 31, Useful Lives (in years) 2021 2020 Lab equipment tooling and molds 4 – 10 $ 8,194 $ 8,053 Office furniture and equipment 6 – 10 1,743 1,760 Leasehold improvements up to 10 1,839 1,838 Computers and software 3 1,939 1,815 Vehicles 5 – 7 37 12 Demo units 5 114 — Total property and equipment 13,866 13,478 Less: Accumulated depreciation (11,197 ) (9,939 ) Total property and equipment, net $ 2,669 $ 3,539
Schedule of Other Current Assets [Table Text Block]	December 31, 2021 2020 Government remittances (1) $ 1,322 $ 1,009 Consideration receivable from subsidiaries sale 1,405 2,580 Deferred financing costs 223 1,063 Sundry assets and miscellaneous 808 1,022 Total other current assets $ 3,758 $ 5,674
Schedule of Accrued Expenses and Other Current Liabilities [Table Text Block]	December 31, 2021 2020 Payroll and related expense $ 1,770 $ 1,312 Accrued expenses 6,584 8,582 Commission accrual 4,529 2,827 Sales and consumption taxes 6,629 7,532 Total accrued expenses and other current liabilities $ 19,512 $ 20,253
Schedule of Product Warranty Liability [Table Text Block]	December 31, 2021 2020 Balance as of the beginning of the year $ 1,639 $ 1,977 Warranties issued during the year 1,231 761 Warranty costs incurred during the year (1,117 ) (1,099 ) Balance at the end of the year $ 1,753 $ 1,639 Current 1,245 1,106 Long-term 508 533 Total $ 1,753 $ 1,639
Schedule of Finance Expenses [Table Text Block]	December 31, 2021 2020 Interest expense $ 3,720 $ 7,615 Accretion on long-term debt and amortization of fees 1,235 728 Total finance expenses $ 4,955 $ 8,343

Note 8 - Intangible Assets an_2

Note 8 - Intangible Assets and Goodwill (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Schedule of Intangible Assets and Goodwill [Table Text Block]	At December 31, 2021 Gross Amount Accumulated Amortization Net Amount Customer relationships $ 1,400 $ (336 ) $ 1,064 Brand 2,500 (803 ) 1,697 Technology 16,900 (6,103 ) 10,797 Supplier agreement 3,000 (1,165 ) 1,835 Total intangible assets $ 23,800 $ (8,407 ) $ 15,393 At December 31, 2020 Gross Amount Accumulated Amortization Net Amount Customer relationships $ 1,400 $ (242 ) $ 1,158 Brand 2,500 (540 ) 1,960 Technology 16,900 (3,286 ) 13,614 Supplier agreement 3,000 (867 ) 2,133 Total intangible assets $ 23,800 $ (4,935 ) $ 18,865
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Years ending December 31, 2022 $ 3,473 2023 3,473 2024 3,473 2025 3,004 2026 657 Thereafter 1,313 Total $ 15,393

Note 9 - Commitments and Cont_2

Note 9 - Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Contractual Obligation, Fiscal Year Maturity [Table Text Block]	Years ending December 31, Office Lease Purchase and Service Commitments Total 2022 $ 1,404 $ 18,551 $ 19,955 2023 1,253 — 1,253 2024 1,108 — 1,108 2025 1,053 — 1,053 2026 1,036 — 1,036 Thereafter 1,240 — 1,240 Total $ 7,094 $ 18,551 $ 25,645

Note 10 - Main Street Term Lo_2

Note 10 - Main Street Term Loan (Tables)	12 Months Ended
	Dec. 31, 2021
MSLP Note [Member]
Notes Tables
Schedule of Maturities of Long-term Debt [Table Text Block]	As of December 31, 2021 2022 $ 1,622 2023 9,357 2024 7,957 2025 38,429 Total $ 57,365

Note 11 - Madryn Long-term De_2

Note 11 - Madryn Long-term Debt and Convertible Notes (Tables)	12 Months Ended
	Dec. 31, 2021
Secured Subordinated Convertible Notes [Member]
Notes Tables
Schedule of Maturities of Long-term Debt [Table Text Block]	As of December 31, 2021 2022 $ 2,165 2023 2,131 2024 1,628 2025 28,217 Total $ 34,141

Note 14 - Common Stock Reserv_2

Note 14 - Common Stock Reserved for Issuance (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Schedule of Common Stock Reserved for Issuance [Table Text Block]	December 31, 2021 December 31, 2020 Outstanding common stock warrants 15,928,867 16,290,067 Outstanding stock options 5,977,179 4,433,392 Shares reserved for future option grants 589,064 262,622 Shares reserved for Lincoln Park 5,222,867 5,222,867 Shares reserved for Madryn Noteholders 8,213,880 8,213,880 Total common stock reserved for issuance 35,931,857 34,422,828

Note 15 - Stockholders Equity (

Note 15 - Stockholders Equity (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Year Ended December 31, 2021 2020 Cost of sales $ 31 $ 25 Selling and marketing 848 872 General and administrative 1,084 1,151 Research and development 105 90 Total stock-based compensation $ 2,068 $ 2,138
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Year Ended December 31, 2021 2020 Expected term (in years) 6.00 6.00 - 6.54 Risk-free interest rate 0.98-1.36 % 0.38 - 1.50 % Expected volatility 44.26 % 42.83 % Expected dividend rate 0 % 0 %
Share-based Payment Arrangement, Option, Activity [Table Text Block]	Number of Shares Weighted- Average Exercise Price per Share, $ Weighted- Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding – January 1, 2021 4,433,392 $ 4.59 6.20 $ 247 Options granted 2,664,500 2.20 - Options exercised (261,836 ) 2.34 92 Options forfeited/cancelled (858,877 ) 4.21 - Outstanding - December 31, 2021 5,977,179 $ 3.72 7.20 $ 136 Exercisable – December 31, 2021 2,907,668 $ 4.52 5.27 $ 136 Expected to vest – after December 31, 2021 3,069,511 $ 2.97 9.03 $ -
Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]	Options Outstanding Options Exercisable Exercise Price Range Number Weighted average remaining contractual term (years) Weighted average Exercise Price Options exercisable Weighted average remaining contractual term (years) Weighted average Exercise Price $1.35 - $3.64 4,675,428 7.46 $ 2.67 1,896,935 4.96 $ 2.92 $4.26 - $7.95 1,250,316 6.32 6.82 965,929 5.88 6.69 $12.45 - $26.10 31,156 6.75 18.02 24,558 6.71 18.19 $27.00 - $33.00 11,900 3.00 27.62 11,882 2.99 27.62 $36.00 - $94.65 8,379 5.69 45.42 8,364 5.69 45.39 5,977,179 7.20 $ 3.72 2,907,668 5.27 $ 4.52

Note 16 - Income Taxes (Tables)

Note 16 - Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]	Year Ended December 31, 2021 2020 United States $ (12,260 ) $ (63,259 ) Other jurisdictions (10,588 ) (18,378 ) Loss before income taxes $ (22,848 ) $ (81,637 )
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	Year Ended December 31, 2021 2020 Current tax (benefit) provision: Federal $ — $ — Foreign (542 ) 1,619 Total current tax (benefit) provision (542 ) 1,619 Deferred tax benefit: Federal — — Foreign (165 ) (438 ) Total deferred tax benefit $ (165 ) $ (438 ) Total (benefit) provision for income taxes $ (707 ) $ 1,181
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	Year Ended December 31, 2021 2020 Loss before income taxes $ (22,848 ) $ (81,637 ) Theoretical tax benefit at the statutory rate ( 21.0 21.0 (4,798 ) (17,144 ) Differences in jurisdictional tax rates (350 ) (2,817 ) Valuation allowance 5,755 12,416 Non-deductible expenses (266 ) 8,080 Other (1,048 ) 646 Total income tax (benefit) provision (707 ) 1,181 Net loss $ (22,141 ) $ (82,818 )
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	December 31, 2021 2020 Deferred tax assets: Property and equipment $ 668 $ 735 Deferred revenue 647 2,065 Allowance for doubtful accounts 3,133 2,670 Intangible assets (1,543 ) (2,554 ) Non-deductible expenses 8,694 8,350 Warranty and other reserves 1,159 729 Other 610 114 Loss carryforwards 38,353 71,362 Valuation allowance (51,437 ) (82,587 ) Total deferred tax assets $ 284 $ 884 Deferred tax liabilities: Deferred revenue $ 46 $ 811 Total deferred tax liabilities $ 46 $ 811
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]	Year Ended December 31, 2021 2020 Balance as of the beginning of the year $ 1,584 $ 1,467 (Reduction) increases related to tax positions in prior period (1,548 ) 57 Increases related to tax positions taken during the current period — 60 Balance at the end of the year $ 36 $ 1,584
Schedule of Recognized Tax Benefits [Table Text Block]	Year Ended December 31, 2021 2020 Balance as of the beginning of the year $ (478 ) $ - Increases related to tax positions in prior period — (369 ) Increase related to tax position taken during the current period (49 ) — Increase related to interest expense (36 ) (109 ) Balance at the end of the year $ (563 ) $ (478 )

Note 17 - Segment and Geograp_2

Note 17 - Segment and Geographic Information (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]	Year Ended December 31, 2021 2020 United States $ 53,520 $ 33,987 International 52,102 44,027 Total revenue $ 105,622 $ 78,014
Revenue from External Customers by Products and Services [Table Text Block]	Year Ended December 31, 2021 2020 Lease revenue $ 45,094 $ 33,428 System revenue 43,106 28,957 Product revenue 13,230 10,858 Service revenue 4,192 4,771 Total revenue $ 105,622 $ 78,014

Note 1 - Nature of Operations (

Note 1 - Nature of Operations (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	Dec. 15, 2021	Dec. 22, 2020	Mar. 19, 2020	Feb. 28, 2021	Dec. 31, 2020	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 09, 2020	Jun. 16, 2020	Mar. 31, 2020
Retained Earnings (Accumulated Deficit), Ending Balance					$ (157,392)	$ (157,392)	$ (180,405)	$ (157,392)
Common Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.0001				$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
Proceeds from Issuance of Private Placement	$ 16,740		$ 20,300
Proceeds from Warrant Exercises							$ 903	$ 0
Gain (Loss) on Disposition of Stock in Subsidiary							$ (567)	$ (2,526)
Maximum [Member]
Percentage of Operating Revenue of Disposed Subsidiaries of Total Revenue							15.00%
December 2020 Public Offering Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)		5,625,000			5,625,000	5,625,000		5,625,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)		$ 2.50			$ 2.50	$ 2.50		$ 2.50
Warrants and Rights Outstanding, Term (Year)		5 years			5 years	5 years		5 years
Class of Warrant or Right, Exercised During Period (in shares)				361,200
Class of Warrant or Right, Exercised During Period, Exercise Price (in dollars per share)				$ 2.50
Proceeds from Warrant Exercises				$ 903
Series A Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.0001		$ 0.0001
Proceeds from Issuance of Private Placement	$ 4,514		$ 8,063
Shares Issued, Price Per Share (in dollars per share)							$ 1.29				$ 2.47
Common Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares)								4,245,256
Proceeds from Issuance of Private Placement	12,074		$ 4,052
The 2021 Private Placement [Member]
Proceeds from Issuance of Private Placement	16,999						$ 16,740	$ 0
Stock Issued, Costs	$ 259
The 2021 Private Placement [Member] | Series A Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares)	3,790,755
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.0001
Convertible Preferred Stock, Shares Issued upon Conversion (in shares)	3,790,755
The 2021 Private Placement [Member] | Common Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares)	9,808,418
Common Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.0001
December 2020 Public Offering [Member]
Stock Issued During Period, Shares, New Issues (in shares)		11,250,000			11,250,000
Common Stock, Par or Stated Value Per Share (in dollars per share)		$ 0.0001
Shares Issued, Price Per Share (in dollars per share)		$ 2
Proceeds from Issuance or Sale of Equity, Total		$ 22,500
Equity Purchase Agreement [Member] | Lincoln Park [Member]
Stock Issued During Period, Shares, New Issues (in shares)						3,037,087	0
Common Stock, Par or Stated Value Per Share (in dollars per share)										$ 0.0001
Shares Issued, Price Per Share (in dollars per share)					$ 2.97	$ 2.97		$ 2.97
Equity Purchase Agreement, Maximum Offering Amount										$ 31,000
Equity Purchase Agreement, Maximum Shares Issuable (in shares)										7,763,411
Equity Agreement, Maximum Percentage of Stock Outstanding										19.99%
Equity Agreement, Minimum Average Purchase Price (in dollars per share)										$ 3.9755
Maximum Percentage of Outstanding Stock, Beneficial Ownership										9.99%
Stock Issued During Period, Shares, Commitment Fee (in shares)						209,566
Stock Issued During Period, Value, Commitment Fee						$ 620
Deferred Offering Costs					$ 123	$ 123		$ 123
Proceeds From Issuance of Common Stock, Gross							$ 9,010
Amortization of Deferred Charges, Total							520
Common Stock, Shares Issued as Commitment Shares, Value							$ 620

Note 2 - Summary of Significa_2

Note 2 - Summary of Significant Accounting Policies (Details Textual) $ in Thousands	Mar. 31, 2020USD ($)	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Accounts Receivable, Allowance for Credit Loss, Ending Balance		$ 11,997	$ 18,490	$ 10,494
Goodwill, Impairment Loss	$ 27,450	0	27,450
Restricted Cash, Current		0	83
Accounts Receivable, Allowance for Credit Loss, Current		11,997	18,490
Impairment, Long-Lived Asset, Held-for-Use, Total		$ 0	0
Number of Reporting Units		1
Lessor, Sales-type Lease, Term of Contract (Month)		36 months
Advertising Expense		$ 1,821	$ 1,092
Minimum [Member]
Discount Based Implicit Interest Rate in Subscription Lease		8.00%
Property, Plant and Equipment, Useful Life (Year)		3 years
Finite-Lived Intangible Asset, Useful Life (Year)		6 years
Standard Product Warranty, Term (Year)		1 year
Maximum [Member]
Discount Based Implicit Interest Rate in Subscription Lease		9.00%
Property, Plant and Equipment, Useful Life (Year)		10 years
Finite-Lived Intangible Asset, Useful Life (Year)		15 years
Standard Product Warranty, Term (Year)		3 years
Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member]
Number of Major Customers		0	0
Accounts Receivable [Member] | Customer Concentration Risk [Member]
Number of Major Customers		0	0
COVID 19 [Member]
Accounts Receivable, Allowance for Credit Loss, Ending Balance		$ 0	$ 11,088

Note 3 - Net Loss Per Share - C

Note 3 - Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Net loss	$ (22,141)	$ (82,818)
Net loss allocated to stockholders of the Company	$ (23,013)	$ (85,270)
Weighted-average shares of common stock outstanding used in computing net loss per share, basic and diluted (in shares)	54,466	36,626
Basic and diluted (in dollars per share)	$ (0.42)	$ (2.33)

Note 3 - Net Loss Per Share - A

Note 3 - Net Loss Per Share - Antidilutive Securities (Details) - shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Total potential dilutive shares (in shares)	21,906,046	20,723,459
Share-based Payment Arrangement, Option [Member]
Total potential dilutive shares (in shares)	5,977,179	4,433,392
Warrant [Member]
Total potential dilutive shares (in shares)	15,928,867	16,290,067

Note 4 - Sale of Subsidiaries (

Note 4 - Sale of Subsidiaries (Details Textual) € in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2020EUR (€)	Sep. 07, 2021
Gain (Loss) on Disposition of Stock in Subsidiary	$ (567)	$ (2,526)
Proceeds from Divestiture of Businesses, Net of Cash Divested, Total	$ (40)	$ (2,101)
Venus Concept Shanghai Co.Ltd [Member]
Business Acquisition, Percentage of Voting Interests Acquired				45.00%
Maximum [Member]
Percentage of Operating Revenue of Disposed Subsidiaries of Total Revenue	15.00%
Venus Concept Africa (Pty) Ltd. [Member] | Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]
Disposal Group, Including Discontinued Operation, Percentage of Ownership	80.00%
Gain (Loss) on Disposition of Stock in Subsidiary	$ (188)
Venus Aesthetic LLP [Member] | Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]
Disposal Group, Including Discontinued Operation, Percentage of Ownership		51.00%	51.00%
Gain (Loss) on Disposition of Stock in Subsidiary		$ (579)
Proceeds from Divestiture of Businesses, Net of Cash Divested, Total		$ 400
Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down	$ 379
Venus Concept Central Eastern Europe Ltd. [Member] | Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]
Disposal Group, Including Discontinued Operation, Percentage of Ownership		51.00%	51.00%
Gain (Loss) on Disposition of Stock in Subsidiary		$ (387)
Proceeds from Divestiture of Businesses, Net of Cash Divested, Total		$ 531	€ 473
Venus Concept Italy S.r.l. [Member] | Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]
Disposal Group, Including Discontinued Operation, Percentage of Ownership		51.00%	51.00%
Gain (Loss) on Disposition of Stock in Subsidiary		$ (547)
Proceeds from Divestiture of Businesses, Net of Cash Divested, Total		$ 330	€ 270
Venus Concept Kazakhstan LLP Foundation Agreement [Member] | Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]
Disposal Group, Including Discontinued Operation, Percentage of Ownership		51.00%	51.00%
Gain (Loss) on Disposition of Stock in Subsidiary		$ 58
Venus Concept RU LLC | Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]
Disposal Group, Including Discontinued Operation, Percentage of Ownership		51.00%	51.00%
Gain (Loss) on Disposition of Stock in Subsidiary		$ (368)
Proceeds from Divestiture of Businesses, Net of Cash Divested, Total		$ 597
Venus Concept Singapore Pte. Ltd (Venus Singapore) [Member] | Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]
Disposal Group, Including Discontinued Operation, Percentage of Ownership		55.00%	55.00%
Gain (Loss) on Disposition of Stock in Subsidiary		$ (670)
Proceeds from Divestiture of Businesses, Net of Cash Divested, Total		$ 500
InPhronics Limited [Member] | Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]
Disposal Group, Including Discontinued Operation, Percentage of Ownership		100.00%	100.00%
PT NeoAsia Medical [Member] | Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]
Disposal Group, Including Discontinued Operation, Percentage of Ownership		90.00%	90.00%
InPhronics Limited and PT NeoAsia Medical [Member] | Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]
Gain (Loss) on Disposition of Stock in Subsidiary		$ (33)
Proceeds from Divestiture of Businesses, Net of Cash Divested, Total		$ 955

Note 5 - Fair Value Measureme_3

Note 5 - Fair Value Measurements (Details Textual) - Contingent Earn-out Consideration [Member] - USD ($) $ in Thousands	Jan. 04, 2021	Nov. 30, 2020	Dec. 31, 2021
Fair Value Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Annual Installment Payable			$ 250
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements	$ 147	$ 500

Note 5 - Fair Value Measureme_4

Note 5 - Fair Value Measurements - Fair Value Measurements (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Assets, fair value	$ 64	$ 147
Total liabilities		147
Contingent Earn-out Consideration [Member]
Total liabilities		147
Guaranteed Investment Certificates [Member]
Assets, fair value	64	64
Restricted Cash [Member]
Assets, fair value		83
Fair Value, Inputs, Level 1 [Member]
Assets, fair value	0	83
Total liabilities		0
Fair Value, Inputs, Level 1 [Member] | Contingent Earn-out Consideration [Member]
Total liabilities		0
Fair Value, Inputs, Level 1 [Member] | Guaranteed Investment Certificates [Member]
Assets, fair value	0	0
Fair Value, Inputs, Level 1 [Member] | Restricted Cash [Member]
Assets, fair value		83
Fair Value, Inputs, Level 2 [Member]
Assets, fair value	64	64
Total liabilities		0
Fair Value, Inputs, Level 2 [Member] | Contingent Earn-out Consideration [Member]
Total liabilities		0
Fair Value, Inputs, Level 2 [Member] | Guaranteed Investment Certificates [Member]
Assets, fair value	64	64
Fair Value, Inputs, Level 2 [Member] | Restricted Cash [Member]
Assets, fair value		0
Fair Value, Inputs, Level 3 [Member]
Assets, fair value	0	0
Total liabilities		147
Fair Value, Inputs, Level 3 [Member] | Contingent Earn-out Consideration [Member]
Total liabilities		147
Fair Value, Inputs, Level 3 [Member] | Guaranteed Investment Certificates [Member]
Assets, fair value	$ 0	0
Fair Value, Inputs, Level 3 [Member] | Restricted Cash [Member]
Assets, fair value		$ 0

Note 5 - Fair Value Measureme_5

Note 5 - Fair Value Measurements - Aggregate Fair Values of Earn-out Liability (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Balance	$ 147	$ 655
Payments	(147)	(799)
Change in value	0	291
Balance	$ 0	$ 147

Note 6 - Accounts Receivable (D

Note 6 - Accounts Receivable (Details Textual) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Lessor, Sales-type Lease, Term of Contract (Month)	36 months
Sales-type and Direct Financing Leases, Lease Receivable	$ 53,887	$ 49,096
Accounts Receivable, Allowance for Credit Loss, Ending Balance	$ 11,997	$ 18,490	$ 10,494

Note 6 - Accounts Receivable -

Note 6 - Accounts Receivable - Summary of Accounts Receivable (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Gross accounts receivable	$ 86,625	$ 92,402
Unearned income	(4,033)	(3,728)
Allowance for doubtful accounts	(11,997)	(18,490)	$ (10,494)
Accounts Receivable, after Allowance for Credit Loss, Total	70,595	70,184
Current trade receivables	46,918	52,764
Current unearned interest income	(2,678)	(1,950)
Long-term trade receivables	27,710	21,148
Long-term unearned interest income	$ (1,355)	$ (1,778)

Note 6 - Accounts Receivable _2

Note 6 - Accounts Receivable - Schedule of Contractual Commitments, Net of Allowance for Doubtful Accounts (Details) $ in Thousands	Dec. 31, 2021USD ($)
2022	$ 26,177
2023	19,256
2024	8,262
2024	192
2025	0
Current Financing Receivables, Net Of Allowance [Member]
Total	26,177
2022	26,177
2023	0
2024	0
2024	0
2025	0
Noncurrent Financing Receivables, Net Of Allowance [Member]
Total	27,710
2022	0
2023	19,256
2024	8,262
2024	192
2025	$ 0

Note 6 - Accounts Receivable _3

Note 6 - Accounts Receivable - Schedule of Contractual Commitments, Net of Allowance for Doubtful Accounts (Details) (Parentheticals) $ in Thousands	Dec. 31, 2021USD ($)
Current Financing Receivables, Net Of Allowance [Member]
Allowance	$ 6,601
Noncurrent Financing Receivables, Net Of Allowance [Member]
Allowance	$ 167

Note 6 - Accounts Receivable _4

Note 6 - Accounts Receivable - Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Balance	$ 18,490	$ 10,494
Write-offs	(6,230)	(6,536)
(Recovery) provision	(263)	15,212
Sale of subsidiaries	0	(680)
Balance	$ 11,997	$ 18,490

Note 7 - Select Balance Sheet_3

Note 7 - Select Balance Sheet and Statement of Operations Information (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cost, Direct Material	$ 26,047	$ 21,258
Inventory Valuation Reserves, Ending Balance	1,456	1,208
Depreciation, Total	$ 1,381	$ 1,331

Note 7 - Select Balance Sheet_4

Note 7 - Select Balance Sheet and Statement of Operations Information - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Raw materials	$ 2,368	$ 838
Work-in-progress	1,649	1,232
Finished goods	16,526	15,689
Total inventory	$ 20,543	$ 17,759

Note 7 - Select Balance Sheet_5

Note 7 - Select Balance Sheet and Statement of Operations Information - Property and Equipment, Net (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Lab equipment tooling and molds	$ 8,194	$ 8,053
Office furniture and equipment	1,743	1,760
Leasehold improvements	1,839	1,838
Computers and software	1,939	1,815
Demo units	114	0
Total property and equipment	13,866	13,478
Less: Accumulated depreciation	(11,197)	(9,939)
Total property and equipment, net	$ 2,669	3,539
Tools, Dies and Molds [Member] | Minimum [Member]
Property and equipment, Useful lives	4
Tools, Dies and Molds [Member] | Maximum [Member]
Property and equipment, Useful lives	10
Office Equipment [Member] | Minimum [Member]
Property and equipment, Useful lives	6
Office Equipment [Member] | Maximum [Member]
Property and equipment, Useful lives	10
Leasehold Improvements [Member] | Maximum [Member]
Property and equipment, Useful lives	up to 10
Computer Equipment [Member]
Property and equipment, Useful lives	3
Vehicles [Member]
Vehicles	$ 37	$ 12
Vehicles [Member] | Minimum [Member]
Property and equipment, Useful lives	5
Vehicles [Member] | Maximum [Member]
Property and equipment, Useful lives	7
Demo Units [Member]
Property and equipment, Useful lives	5

Note 7 - Select Balance Sheet_6

Note 7 - Select Balance Sheet and Statement of Operations Information - Other Current Assets (Details) - USD ($) $ in Thousands		Dec. 31, 2021	Dec. 31, 2020
Government remittances (1)	[1]	$ 1,322	$ 1,009
Consideration receivable from subsidiaries sale		1,405	2,580
Deferred financing costs		223	1,063
Sundry assets and miscellaneous		808	1,022
Total other current assets		$ 3,758	$ 5,674
[1]	Government remittances are receivables from the local tax authorities for refund of sales taxes and income taxes.

Note 7 - Select Balance Sheet_7

Note 7 - Select Balance Sheet and Statement of Operations Information - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Payroll and related expense	$ 1,770	$ 1,312
Accrued expenses	6,584	8,582
Commission accrual	4,529	2,827
Sales and consumption taxes	6,629	7,532
Total accrued expenses and other current liabilities	$ 19,512	$ 20,253

Note 7 - Select Balance Sheet_8

Note 7 - Select Balance Sheet and Statement of Operations Information - Warranty Accrual (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Balance as of the beginning of the year	$ 1,639	$ 1,977
Warranties issued during the year	1,231	761
Warranty costs incurred during the year	(1,117)	(1,099)
Balance at the end of the year	1,753	1,639
Current	1,245	1,106
Long-term	508	533
Total	$ 1,753	$ 1,639

Note 7 - Select Balance Sheet_9

Note 7 - Select Balance Sheet and Statement of Operations Information - Finance Expenses (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Interest expense	$ 3,720	$ 7,615
Accretion on long-term debt and amortization of fees	1,235	728
Total finance expenses	$ 4,955	$ 8,343

Note 8 - Intangible Assets an_3

Note 8 - Intangible Assets and Goodwill (Details Textual) $ in Thousands	Mar. 31, 2020USD ($)	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Nov. 07, 2019USD ($)
Number of Reporting Units		1
Goodwill, Impairment Loss	$ 27,450	$ 0	$ 27,450
Amortization of Intangible Assets, Total		$ 3,473	$ 3,473
Venus Concept Ltd. [Member]
Goodwill, Ending Balance				$ 24,847
Venus Concept Ltd. [Member] | Technology [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total				16,900
Venus Concept Ltd. [Member] | Brand Name [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total				$ 1,200

Note 8 - Intangible Assets an_4

Note 8 - Intangible Assets and Goodwill - Schedule of Intangible Assets Net of Accumulated Amortization and Goodwill (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Gross Amount	$ 23,800	$ 23,800
Accumulated amortization	(8,407)	(4,935)
Net Amount	15,393	18,865
Customer Relationships [Member]
Gross Amount	1,400	1,400
Accumulated amortization	(336)	(242)
Net Amount	1,064	1,158
Brand [Member]
Gross Amount	2,500	2,500
Accumulated amortization	(803)	(540)
Net Amount	1,697	1,960
Technology [Member]
Gross Amount	16,900	16,900
Accumulated amortization	(6,103)	(3,286)
Net Amount	10,797	13,614
Supplier Agreement [Member]
Gross Amount	3,000	3,000
Accumulated amortization	(1,165)	(867)
Net Amount	$ 1,835	$ 2,133

Note 8 - Intangible Assets an_5

Note 8 - Intangible Assets and Goodwill - Estimated Amortization (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
2022	$ 3,473
2023	3,473
2024	3,473
2025	3,004
2026	657
Thereafter	1,313
Total	$ 15,393	$ 18,865

Note 9 - Commitments and Cont_3

Note 9 - Commitments and Contingencies (Details Textual) ¥ in Thousands, $ in Thousands	Mar. 04, 2021USD ($)	Mar. 04, 2021CNY (¥)	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)
Operating Lease, Expense			$ 2,187	$ 1,961
Purchase Obligation, Total			18,551
Regulated Operation [Member]
Payments for Legal Settlements	$ 150	¥ 976
Contract Manufacturers [Member]
Purchase Obligation, Total			17,598
Open Purchase Order [Member]
Purchase Obligation, Total			$ 6,352
Percentage Of Open Purchase Order			15.00%

Note 9 - Commitments and Cont_4

Note 9 - Commitments and Contingencies - Aggregate Future Minimum Lease Payments (Details) $ in Thousands	Dec. 31, 2021USD ($)
2022, office lease	$ 1,404
2022, purchase and service commitments	18,551
2022, total	19,955
2023, office lease	1,253
2023, total	1,253
2024, office lease	1,108
2024, total	1,108
2025, office lease	1,053
2025, total	1,053
2026, office lease	1,036
2026, total	1,036
Thereafter, office lease	1,240
Thereafter, total	1,240
Total, office lease	7,094
Purchase and service commitments	18,551
Total, total	$ 25,645

Note 10 - Main Street Term Lo_3

Note 10 - Main Street Term Loan (Details Textual) - MSLP Note [Member] - USD ($) $ in Millions	Dec. 08, 2020	Dec. 08, 2024
Debt Instrument, Face Amount	$ 50
Debt Instrument, Term (Year)	5 years
Forecast [Member]
Debt Instrument, Percentage of Outstanding Principal to be Paid with Accrued Unpaid Interest		15.00%
London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument, Basis Spread on Variable Rate	3.00%

Note 10 - Main Street Term Lo_4

Note 10 - Main Street Term Loan - Schedule Payments on Outstanding Borrowings (Details) - MSLP Note [Member] $ in Thousands	Dec. 31, 2021USD ($)
2022	$ 1,622
2023	9,357
2024	7,957
2025	38,429
Total	$ 57,365

Note 11 - Madryn Long-term De_3

Note 11 - Madryn Long-term Debt and Convertible Notes (Details Textual) - USD ($)	Dec. 09, 2020	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Dec. 15, 2021	Apr. 29, 2020	Oct. 14, 2018	Aug. 14, 2018	Aug. 04, 2018	Oct. 11, 2016
Common Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.0001			$ 0.0001	$ 0.0001	$ 0.0001			$ 0.0001
Madryn Credit Agreement [Member]
Repayments of Debt	$ 42,500,000
Madryn Credit Agreement [Member] | Madryn Noteholders [Member]
Debt Instrument, Face Amount														$ 70,000,000
Debt Instrument, Interest Rate, Stated Percentage		10.50%	10.50%				10.50%			12.00%	9.00%		9.00%
Debt Instrument, Covenant, Minimum Revenue Threshold							$ 75,000,000	$ 85,000,000
Debt Instrument, Covenant, Minimum Cash Proceeds from Issuance of Equity			$ 5,000,000
Debt Instrument, Covenant, Best Effort, Additional Proceeds from Issuance of Equity,			2,000,000
Debt Instrument, Interest Rate, Percentage Paid in Cash		50.00%
Debt Instrument, Interest Rate, Percentage Paid in Kind		50.00%
Madryn Credit Agreement [Member] | Madryn Noteholders [Member] | Interest Only Period [Member]
Debt Instrument, Interest Rate, Stated Percentage												9.00%
Madryn Credit Agreement [Member] | Madryn Noteholders [Member] | Term A-1, A-2 and B Tranches of Debt [Member]
Long-term Debt, Gross		$ 60,000,000	$ 60,000,000				$ 60,000,000
Secured Subordinated Convertible Notes [Member] | Madryn Noteholders [Member]
Debt Instrument, Face Amount	$ 26,695,000
Debt Instrument, Default, Increase in Interest Rate	4.00%
Debt Instrument, Termination, Minimum Principal Outstanding	$ 10,000
Debt Instrument, Convertible, Conversion Price (in dollars per share)	$ 3.25
Interest Expense, Total					$ 2,158,000
Repayments of Long-term Debt, Total				$ 0		$ 0
Debt Instrument, Maturity Date	Dec. 9, 2025
Secured Subordinated Convertible Notes [Member] | Madryn Noteholders [Member] | Original Issuance Of Notes To Third Anniversary Date [Member]
Debt Instrument, Interest Rate, Stated Percentage	8.00%
Secured Subordinated Convertible Notes [Member] | Madryn Noteholders [Member] | After the Third Anniversary [Member]
Debt Instrument, Interest Rate, Stated Percentage	6.00%

Note 11 - Madryn Long-term De_4

Note 11 - Madryn Long-term Debt and Convertible Notes - Scheduled Payments (Details) - Secured Subordinated Convertible Notes [Member] $ in Thousands	Dec. 31, 2021USD ($)
2022	$ 2,165
2023	2,131
2024	1,628
2025	28,217
Total	$ 34,141

Note 12 - Credit Facility (Deta

Note 12 - Credit Facility (Details Textual) - City National Bank of Florida [Member] - USD ($) $ in Millions	Aug. 26, 2021	Dec. 09, 2020
CNB Note [Member]
Debt Instrument, Face Amount	$ 5
Debt Instrument, Maturity Date	Jul. 24, 2023
Revolving Credit Facility [Member]
Line of Credit Facility, Cash Held In Deposit Account		$ 23
Line of Credit Facility, Minimum Deposit Required	$ 1.5	3
Escrow Deposit		20
Loan Processing Fee		1
Line of Credit Facility, Maximum Borrowing Capacity	$ 5	$ 10
Debt Instrument, LIBOR Floor	0.50%
Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument, Basis Spread on Variable Rate	3.25%

Note 13 - Government Assistan_2

Note 13 - Government Assistance Programs (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Aug. 29, 2020	Apr. 20, 2020
Subsidiaries [Member]
Government Subsidies	$ 1,117
SBA CARES Act Paycheck Protection Program [Member]
Proceeds from Loans	4,048
Long-term Debt, Total	543	$ 4,110
SBA CARES Act Paycheck Protection Program [Member] | Venus Concept Inc [Member]
Debt Instrument, Face Amount			$ 1,665
Debt Instrument, Decrease, Forgiveness	1,086
SBA CARES Act Paycheck Protection Program [Member] | Venus USA [Member]
Debt Instrument, Face Amount				$ 2,383
Debt Instrument, Decrease, Forgiveness	$ 1,689

Note 14 - Common Stock Reserv_3

Note 14 - Common Stock Reserved for Issuance - Common Stock Reserved for Issuance (Details) - shares	Dec. 31, 2021	Dec. 31, 2020
Outstanding stock options (in shares)	5,977,179	4,433,392
Total common stock reserved for issuance (in shares)	35,931,857	34,422,828
Lincoln Park [Member]
Total common stock reserved for issuance (in shares)	5,222,867	5,222,867
Madryn Noteholders [Member]
Total common stock reserved for issuance (in shares)	8,213,880	8,213,880
Share-based Payment Arrangement, Option [Member]
Shares reserved for future option grants (in shares)	589,064	262,622
Common Stock [Member]
Outstanding common stock warrants (in shares)	15,928,867	16,290,067

Note 15 - Stockholders Equity_2

Note 15 - Stockholders Equity (Details Textual) $ / shares in Units, $ in Thousands	Dec. 15, 2021USD ($)$ / shares	Dec. 22, 2020$ / sharesshares	Jun. 16, 2020shares	Mar. 19, 2020USD ($)$ / sharesshares	Dec. 31, 2020$ / sharesshares	Mar. 31, 2020USD ($)$ / sharesshares	Nov. 30, 2017	Nov. 30, 2010	Dec. 31, 2021USD ($)$ / sharesshares	Dec. 31, 2020USD ($)$ / sharesshares	Dec. 09, 2020$ / shares	Oct. 04, 2019shares
Preferred Stock, Convertible, Conversion Ratio	1
Adjustments to Additional Paid in Capital, Convertible Preferred Stock with Beneficial Conversion Feature | $	$ 152			$ 3,564					$ 152
Proceeds from Issuance of Private Placement | $	$ 16,740			20,300
Common Stock, Capital Shares Reserved for Future Issuance (in shares)					34,422,828				35,931,857	34,422,828
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments | $									$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | $									$ 92	$ 464
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares									$ 2.20	$ 4.17
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares	$ 0.0001				$ 0.0001				$ 0.0001	$ 0.0001	$ 0.0001
The 2010 Share Option Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)							10 years	7 years
Common Stock, Capital Shares Reserved for Future Issuance (in shares)					138,275				212,650	138,275
The 2019 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)												450,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares)					124,347				376,414	124,347
Share-based Compensation Arrangement by Share-based Payment Award, Increase in Authorized Shares, Percentage of Outstanding Stock Maximum									4.00%
December 2020 Public Offering [Member]
Shares Issued, Price Per Share (in dollars per share) | $ / shares		$ 2
Stock Issued During Period, Shares, New Issues (in shares)		11,250,000			11,250,000
Common Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares		$ 0.0001
Series A Preferred Stock Converted into Common Stock [Member]
Conversion of Stock, Shares Converted (in shares)			660,000
Conversion of Stock, Shares Issued (in shares)			6,600,000
The 2020 Private Placement Warrants [Member]
Proceeds from Issuance of Private Placement | $				$ 4,621
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)				6,675,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares				$ 3.50
Warrants and Rights Outstanding, Term (Year)				5 years
Warrants and Rights Outstanding, Exercisable Period (Day)				181 days
December 2020 Public Offering Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)		5,625,000			5,625,000					5,625,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares		$ 2.50			$ 2.50					$ 2.50
Warrants and Rights Outstanding, Term (Year)		5 years			5 years					5 years
Common Stock [Member]
Adjustments to Additional Paid in Capital, Convertible Preferred Stock with Beneficial Conversion Feature | $									$ 0
Proceeds from Issuance of Private Placement | $	$ 12,074			$ 4,052
Stock Issued During Period, Shares, New Issues (in shares)										4,245,256
Series A Preferred Stock [Member]
Preferred Stock, Shares Outstanding, Ending Balance (in shares)						660,000			3,790,755
Preferred Stock, Convertible, Conversion Ratio						10			1
Preferred Stock, Maximum Conversion Cap Percentage						19.99%			9.99%
Dividends Payable | $						$ 0			$ 0
Preferred Stock, Convertible, Conversion Price (in dollars per share) | $ / shares						$ 1.93			$ 1.25
Shares Issued, Price Per Share (in dollars per share) | $ / shares						$ 2.47			$ 1.29
Adjustments to Additional Paid in Capital, Convertible Preferred Stock with Beneficial Conversion Feature | $						$ 3,564			$ 152
Proceeds from Issuance of Private Placement | $	$ 4,514			$ 8,063
Preferred Stock, Par or Stated Value Per Share (in dollars per share) | $ / shares	$ 0.0001			$ 0.0001

Note 15 - Stockholders Equity -

Note 15 - Stockholders Equity - Stock-based Compensation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Total stock-based compensation	$ 2,068	$ 2,138
Cost of Sales [Member]
Total stock-based compensation	31	25
Selling and Marketing Expense [Member]
Total stock-based compensation	848	872
General and Administrative Expense [Member]
Total stock-based compensation	1,084	1,151
Research and Development Expense [Member]
Total stock-based compensation	$ 105	$ 90

Note 15 - Stockholders Equity_3

Note 15 - Stockholders Equity - Stock Options Assumptions (Details)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Expected term (in years) (Year)	6 years
Expected volatility	44.26%	42.83%
Expected dividend rate	0.00%	0.00%
Minimum [Member]
Expected term (in years) (Year)		6 years
Risk-free interest rate	0.98%	0.38%
Maximum [Member]
Expected term (in years) (Year)		6 years 6 months 14 days
Risk-free interest rate	1.36%	1.50%

Note 15 - Stockholders Equity_4

Note 15 - Stockholders Equity - Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Outstanding, number of shares (in shares)	4,433,392
Outstanding, weighted average exercise price (in dollars per share)	$ 4.59
Outstanding, weighted average remaining contractual term (Year)	7 years 2 months 12 days	6 years 2 months 12 days
Outstanding, aggregate intrinsic value	$ 136	$ 247
Options granted, number of shares (in shares)	2,664,500
Options granted, weighted average exercise price (in dollars per share)	$ 2.20
Options granted, aggregate intrinsic value	$ 0
Options exercised, number of shares (in shares)	(261,836)
Options exercised, weighted average exercise price (in dollars per share)	$ 2.34
Options exercised, aggregate intrinsic value	$ 92	$ 464
Options forfeited/cancelled, number of shares (in shares)	(858,877)
Options forfeited/cancelled, weighted average exercise price (in dollars per share)	$ 4.21
Options forfeited/cancelled, aggregate intrinsic value (in dollars per share)	$ 0
Outstanding, number of shares (in shares)	5,977,179	4,433,392
Outstanding, weighted average exercise price (in dollars per share)	$ 3.72	$ 4.59
Exercisable, number of shares (in shares)	2,907,668
Exercisable, weighted average exercise price (in dollars per share)	$ 4.52
Exercisable, weighted average remaining contractual term (Year)	5 years 3 months 7 days
Exercisable, aggregate intrinsic value	$ 136
Expected to vest, number of shares (in shares)	3,069,511
Expected to vest, weighted average exercise price (in dollars per share)	$ 2.97
Expected to vest, weighted average remaining contractual term (Year)	9 years 10 days
Expected to vest, aggregate intrinsic value	$ 0

Note 15 - Stockholders Equity_5

Note 15 - Stockholders Equity - Stock Options Outstanding and Exercisable (Details)	12 Months Ended
	Dec. 31, 2021$ / sharesshares
Options outstanding, number (in shares) | shares	5,977,179
Options outstanding, weighted average remaining contractual term (Year)	7 years 2 months 12 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 3.72
Options exercisable (in shares) | shares	2,907,668
Options exercisable, weighted average remaining contractual term (Year)	5 years 3 months 7 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 4.52
Range One [Member]
Exercise price range, lower limit (in dollars per share)	1.35
Exercise price range, upper limit (in dollars per share)	$ 3.64
Options outstanding, number (in shares) | shares	4,675,428
Options outstanding, weighted average remaining contractual term (Year)	7 years 5 months 15 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 2.67
Options exercisable (in shares) | shares	1,896,935
Options exercisable, weighted average remaining contractual term (Year)	4 years 11 months 15 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 2.92
Range Two [Member]
Exercise price range, lower limit (in dollars per share)	4.26
Exercise price range, upper limit (in dollars per share)	$ 7.95
Options outstanding, number (in shares) | shares	1,250,316
Options outstanding, weighted average remaining contractual term (Year)	6 years 3 months 25 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 6.82
Options exercisable (in shares) | shares	965,929
Options exercisable, weighted average remaining contractual term (Year)	5 years 10 months 17 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 6.69
Range Three [Member]
Exercise price range, lower limit (in dollars per share)	12.45
Exercise price range, upper limit (in dollars per share)	$ 26.10
Options outstanding, number (in shares) | shares	31,156
Options outstanding, weighted average remaining contractual term (Year)	6 years 9 months
Options outstanding, weighted average exercise price (in dollars per share)	$ 18.02
Options exercisable (in shares) | shares	24,558
Options exercisable, weighted average remaining contractual term (Year)	6 years 8 months 15 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 18.19
Range Four [Member]
Exercise price range, lower limit (in dollars per share)	27
Exercise price range, upper limit (in dollars per share)	$ 33
Options outstanding, number (in shares) | shares	11,900
Options outstanding, weighted average remaining contractual term (Year)	3 years
Options outstanding, weighted average exercise price (in dollars per share)	$ 27.62
Options exercisable (in shares) | shares	11,882
Options exercisable, weighted average remaining contractual term (Year)	2 years 11 months 26 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 27.62
Range Five [Member]
Exercise price range, lower limit (in dollars per share)	36
Exercise price range, upper limit (in dollars per share)	$ 94.65
Options outstanding, number (in shares) | shares	8,379
Options outstanding, weighted average remaining contractual term (Year)	5 years 8 months 8 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 45.42
Options exercisable (in shares) | shares	8,364
Options exercisable, weighted average remaining contractual term (Year)	5 years 8 months 8 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 45.39

Note 16 - Income Taxes (Details

Note 16 - Income Taxes (Details Textual) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Deferred Tax Assets, Valuation Allowance, Total	$ 51,437	$ 82,587
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	31,150	26,433
Deferred Tax Assets, Net of Valuation Allowance, Total	284	884
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total	0	0
Research Tax Credit Carryforward [Member]
Tax Credit Carryforward, Amount	119	0
Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member]
Operating Loss Carryforwards, Total	$ 163,395	$ 285,094

Note 16 - Income Taxes - Schedu

Note 16 - Income Taxes - Schedule of Geographical Breakdown of Loss Before Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
United States	$ (12,260)	$ (63,259)
Other jurisdictions	(10,588)	(18,378)
Loss before income taxes	$ (22,848)	$ (81,637)

Note 16 - Income Taxes - Sche_2

Note 16 - Income Taxes - Schedule of Components of Provision for Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Current tax (benefit) provision:
Federal	$ 0	$ 0
Foreign	(542)	1,619
Total current tax (benefit) provision	(542)	1,619
Deferred tax benefit:
Federal	0	0
Foreign	(165)	(438)
Total deferred tax benefit	(165)	(438)
Total (benefit) provision for income taxes	$ (707)	$ 1,181

Note 16 - Income Taxes - Reconc

Note 16 - Income Taxes - Reconciliation of Income Tax Expense (Benefit) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Loss before income taxes	$ (22,848)	$ (81,637)
Theoretical tax benefit at the statutory rate (21.0% in 2021, 21.0% in 2020)	(4,798)	(17,144)
Differences in jurisdictional tax rates	(350)	(2,817)
Valuation allowance	5,755	12,416
Non-deductible expenses	(266)	8,080
Other	(1,048)	646
Total (benefit) provision for income taxes	(707)	1,181
Net loss	$ (22,141)	$ (82,818)

Note 16 - Income Taxes - Reco_2

Note 16 - Income Taxes - Reconciliation of Income Tax Expense (Benefit) (Details) (Parentheticals)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Statutory Rate	21.00%	21.00%

Note 16 - Income Taxes - Sche_3

Note 16 - Income Taxes - Schedule of Components of Deferred Tax Assets and Deferred Tax Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Deferred tax assets:
Property and equipment	$ 668	$ 735
Deferred revenue	647	2,065
Allowance for doubtful accounts	3,133	2,670
Intangible assets	(1,543)	(2,554)
Non-deductible expenses	8,694	8,350
Warranty and other reserves	1,159	729
Other	610	114
Loss carryforwards	38,353	71,362
Valuation allowance	(51,437)	(82,587)
Total deferred tax assets	284	884
Deferred tax liabilities:
Deferred revenue	46	811
Total deferred tax liabilities	$ 46	$ 811

Note 16 - Income Taxes - Sche_4

Note 16 - Income Taxes - Schedule of Reconciliation of Uncertain Tax Position (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Balance as of the beginning of the year	$ 1,584	$ 1,467
Reduction related to tax positions in prior period	(1,548)
Increases related to tax positions in prior period		57
Increases related to tax positions taken during the current period	0	60
Balance at the end of the year	$ 36	$ 1,584

Note 16 - Income Taxes - Sche_5

Note 16 - Income Taxes - Schedule of Tax Effected Amount of Recognized Tax Position (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Balance as of the beginning of the year	$ (478)	$ 0
Increases related to tax positions in prior period	0	(369)
Increase related to tax position taken during the current period	(49)	0
Increase related to interest expense	(36)	(109)
Balance at the end of the year	$ (563)	$ (478)

Note 17 - Segment and Geograp_3

Note 17 - Segment and Geographic Information (Details Textual) $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)
Number of Reportable Segments	1
Number of Operating Segments	1
Leases [Member]
Sales with Typical Lease Terms (Month)	36 months
System [Member]
Sales with Payment Terms (Month)	12 months
UNITED STATES
Long-Lived Assets	$ 16,090	$ 19,828
Non-US [Member]
Long-Lived Assets	$ 1,972	$ 2,576

Note 17 - Segment and Geograp_4

Note 17 - Segment and Geographic Information - Schedule of Revenue by Geographic Area (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Total revenue	$ 105,622	$ 78,014
UNITED STATES
Total revenue	53,520	33,987
Non-US [Member]
Total revenue	$ 52,102	$ 44,027

Note 17 - Segment and Geograp_5

Note 17 - Segment and Geographic Information - Schedule of Revenue by Type (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Total revenue	$ 105,622	$ 78,014
Leases [Member]
Total revenue	45,094	33,428
System [Member]
Total revenue	43,106	28,957
Product [Member]
Total revenue	13,230	10,858
Service [Member]
Total revenue	$ 4,192	$ 4,771

Note 18 - Related Party Trans_2

Note 18 - Related Party Transactions (Details Textual) $ / shares in Units, $ in Thousands, $ in Millions	Dec. 15, 2021USD ($)shares	Mar. 19, 2020USD ($)$ / sharesshares	Mar. 05, 2020USD ($)	Mar. 05, 2020SGD ($)	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)shares	Jan. 01, 2021	Mar. 31, 2020	Jan. 01, 2018
Preferred Stock, Convertible, Conversion Ratio	1
Proceeds from Issuance of Private Placement	$ 16,740	$ 20,300
Dividends, Total			$ 289	$ 0.4
Venus Concept Singapore Pte. Ltd (Venus Singapore) [Member]
Disposal Group, Including Discontinued Operation, Percentage of Ownership						55.00%
Senior Officer [Member] | Technicalbiomed Co., Ltd. (TBC) [Member]
Equity Method Investment, Ownership Percentage							45.00%		30.00%
Technicalbiomed Co., Ltd. (TBC) [Member]
Revenue from Related Parties					$ 537	$ 278
Venus Concept Singapore Pte. Ltd (Venus Singapore) [Member]
Revenue from Related Parties					$ 239	239
Senior Officer [Member]
Dividends, Total			$ 130
Percentage of Dividend Distribution			45.00%	45.00%
The 2020 Private Placement Warrants [Member]
Proceeds from Issuance of Private Placement		$ 4,621
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares		6,675,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares		$ 3.50
Series A Preferred Stock [Member]
Preferred Stock, Convertible, Conversion Ratio					1			10
Proceeds from Issuance of Private Placement	4,514	$ 8,063
The 2021 Private Placement [Member]
Proceeds from Issuance of Private Placement	$ 16,999				$ 16,740	0
The 2021 Private Placement [Member] | Series A Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares	3,790,755
The 2021 Private Placement [Member] | Certain Investors [Member]
Proceeds from Issuance of Private Placement	$ 16,999	$ 22,250
The 2020 Private Placement [Member]
Proceeds from Issuance of Private Placement					$ 0	$ 20,300
The 2020 Private Placement [Member] | Conversion of Series A Convertible Preferred Stock To Common Stock [Member]
Conversion of Stock, Shares Converted (in shares) | shares		660,000
Conversion of Stock, Shares Issued (in shares) | shares		6,600,000
Common Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares						4,245,256
Proceeds from Issuance of Private Placement	$ 12,074	$ 4,052
Common Stock [Member] | The 2021 Private Placement [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares	9,808,418
Common Stock [Member] | The 2021 Private Placement [Member] | Certain Investors [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares	9,808,418	2,300,000
Preferred Stock [Member] | Series A Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares						0
Preferred Stock [Member] | The 2021 Private Placement [Member] | Certain Investors [Member] | Series A Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares) | shares	3,790,755

Note 19 - Subsequent Events (De

Note 19 - Subsequent Events (Details Textual) - The 2019 Plan [Member] - shares	Mar. 24, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares)		376,414	124,347
Subsequent Event [Member] | Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares)	356,250